{ "$schema_version": "5.3", "review_mode": "fresh", "claim_restatement": { "index_wording": "Metformin as Geroprotector", "entry_form": "claim", "gradeable_restatement": "Metformin slows biological aging in non-diabetic humans and extends healthspan.", "restatement_required": true, "split_into": [], "parent_claim": null, "scope_qualifiers": [ { "qualifier": "Enrollment, product identity, disease, species, baseline state and treatment timing", "determinable_before_outcome": true, "determined_from": "Enrollment and experimental design, before results; no responder-defined scope.", "action": "retained" } ] }, "hypothesis": { "name": "Metformin as Geroprotector", "central_claim": "Metformin slows biological aging in non-diabetic humans and extends healthspan.", "proposed_mechanism": "Metformin slows biological aging in non-diabetic humans and extends healthspan.", "claimed_scope": "Metformin slows organismal aging and improves broad healthspan in people without diabetes", "claimed_level": [ "progression" ], "is_conjunctive": true, "conjunctive_note": "The website claim hinges on SC3 at its stated scope; SC1 and SC2 are reported separately and cannot substitute for that claim." }, "rubric_routing": { "primary_rubric": "06-metabolism-aging.md", "secondary_rubrics": [], "index_notes_applied": [ "The website claim hinges on SC3 at its stated scope; SC1 and SC2 are reported separately and cannot substitute for that claim." ], "rubric_fit_note": "06-metabolism-aging directly governs organismal-aging and healthspan claims. Specific molecular causality is distinguished from aging causality; SC2 deliberately scores constrained model outcomes rather than extrapolating them to SC3." }, "subclaim_matrix": { "subclaims": [ { "id": "SC1", "statement": "Metformin changes aging-related metabolic pathways.", "subclaim_type": "mechanism", "scope": "Experimental models and non-diabetic adults", "claimed_scope": "Experimental models and non-diabetic adults", "governing_rubric": "06-metabolism-aging.md", "key_evidence_anchor": "Pathway perturbation studies", "hsef_level": "Γ", "confidence": "Moderate", "governing_cap_or_threshold": "Quoted boundary and upward audit below.", "rationale": "Metformin has specific experimentally demonstrated molecular/pathway effects, but aging attribution cannot be established by AMPK, redox, senescence or clock markers alone." }, { "id": "SC2", "statement": "Metformin extends organismal lifespan or functional healthspan in model systems.", "subclaim_type": "generalization", "scope": "Species, sex and dose defined before outcomes", "claimed_scope": "Species, sex and dose defined before outcomes", "governing_rubric": "06-metabolism-aging.md", "key_evidence_anchor": "Controlled survival and function studies with intake controls", "hsef_level": "Ε", "confidence": "Moderate", "governing_cap_or_threshold": "Quoted boundary and upward audit below.", "rationale": "Defined model interventions change survival/function in worms, flies and selected mammals. Ε is restricted to demonstrated species, genotype, timing and exposure; negative and toxic contexts prevent a universal model claim." }, { "id": "SC3", "statement": "Metformin slows aging and extends healthspan in non-diabetic humans.", "subclaim_type": "generalization", "scope": "Adults without diabetes at enrollment", "claimed_scope": "Adults without diabetes at enrollment", "governing_rubric": "06-metabolism-aging.md", "key_evidence_anchor": "Randomized age-related disease or functional trajectory endpoints", "hsef_level": "Γ", "confidence": "Moderate", "governing_cap_or_threshold": "Quoted boundary and upward audit below.", "rationale": "Non-diabetic high-risk people obtain genuine diabetes prevention, but this does not establish slower general aging or broad functional healthspan. Short biomarkers and diabetic observational survival cannot supply that missing clinical claim." } ], "aggregation_rule": "primary-subclaim", "aggregation_preregistered": true, "aggregation_rationale": "The website claim hinges on SC3 at its stated scope; SC1 and SC2 are reported separately and cannot substitute for that claim.", "primary_subclaim_id": "SC3", "aggregation_derivation": "Overall Γ applies to SC3. Context-specific animal function/survival and genuine prevention of diabetes do not establish generalized human aging slowing. The strongest model results are retained at Ε within their tested settings, with dose, timing, sex, diet and statistical boundaries explicit.", "aggregation_alternatives": { "weakest_link_would_return": "Γ", "primary_subclaim_would_return": "Γ", "scope_matched_would_return": "Γ", "note": "Separate narrow successes do not replace the preregistered gate." }, "index_rule_deviation": "" }, "competing_models": { "models_evaluated": [ { "rank_in_tournament": 1, "model_id": "M2", "is_nominal": false, "name": "Context-specific metabolic and stress effects", "core_claim": "Metformin can improve particular metabolic, disease or model outcomes without a uniform general-aging effect.", "explains_what_nominal_does_not": "Metformin can improve particular metabolic, disease or model outcomes without a uniform general-aging effect.", "strongest_supporting_evidence": [ "DPP prevention and constrained animal functional/survival effects are causal." ], "strongest_contradictory_evidence": [ "This does not prove broad human healthspan or all proposed stress pathways." ], "hsef_level_for_this_model": "Ε", "rationale": "DPP prevention and constrained animal functional/survival effects are causal. This does not prove broad human healthspan or all proposed stress pathways." }, { "rank_in_tournament": 2, "model_id": "M1", "is_nominal": true, "name": "General human geroprotection", "core_claim": "Modifying metformin-responsive pathways slows aging and improves healthspan in people without diabetes.", "explains_what_nominal_does_not": "Modifying metformin-responsive pathways slows aging and improves healthspan in people without diabetes.", "strongest_supporting_evidence": [ "Model lifespan/function, monkey outcomes and human mechanistic markers support plausibility." ], "strongest_contradictory_evidence": [ "Human generalized aging trajectories are unestablished; exercise and model boundary results constrain robustness." ], "hsef_level_for_this_model": "Γ", "rationale": "Model lifespan/function, monkey outcomes and human mechanistic markers support plausibility. Human generalized aging trajectories are unestablished; exercise and model boundary results constrain robustness." }, { "rank_in_tournament": 3, "model_id": "M3", "is_nominal": false, "name": "Diet/microbe-mediated model benefit", "core_claim": "Altered intake or bacterial metabolism can explain selected lifespan effects.", "explains_what_nominal_does_not": "Altered intake or bacterial metabolism can explain selected lifespan effects.", "strongest_supporting_evidence": [ "Worm bacterial/methionine dependencies and human appetite effects directly motivate this rival." ], "strongest_contradictory_evidence": [ "They do not explain every specific mammalian pathway effect." ], "hsef_level_for_this_model": "Γ", "rationale": "Worm bacterial/methionine dependencies and human appetite effects directly motivate this rival. They do not explain every specific mammalian pathway effect." }, { "rank_in_tournament": 4, "model_id": "M4", "is_nominal": false, "name": "Selection in observational survival", "core_claim": "Treatment eligibility and disease/control differences can produce apparent mortality advantages.", "explains_what_nominal_does_not": "Treatment eligibility and disease/control differences can produce apparent mortality advantages.", "strongest_supporting_evidence": [ "Diabetic observational comparisons change with follow-up and selection assumptions." ], "strongest_contradictory_evidence": [ "This cannot negate randomized disease prevention or all model interventions." ], "hsef_level_for_this_model": "Β", "rationale": "Diabetic observational comparisons change with follow-up and selection assumptions. This cannot negate randomized disease prevention or all model interventions." } ], "tournament_summary": "Descriptive comparison; does not modify the nominal score. A sufficiently long randomized non-diabetic aging/function study with prespecified baseline and nutritional controls would separate broad geroprotection from disease prevention, caloric effects and treatment-selection artifacts.", "study_separating_rank1_from_rank2": "A sufficiently long randomized non-diabetic aging/function study with prespecified baseline and nutritional controls would separate broad geroprotection from disease prevention, caloric effects and treatment-selection artifacts.", "nominal_wins_only_by_funding_artifact": false, "level_unchanged_by_tournament": true }, "evidence_inventory": [ { "n": 1, "pmid": "35114355", "title": "Activation of autophagy attenuates motor deficits and extends lifespan in a C. elegans model of ALS.", "citation": "Xu H, Jia C, Cheng C et al. Activation of autophagy attenuates motor deficits and extends lifespan in a C. elegans model of ALS. Free radical biology & medicine. 2022.", "doi": "10.1016/j.freeradbiomed.2022.01.030", "pmcid": "PMC8996503", "url": "https://pubmed.ncbi.nlm.nih.gov/35114355/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/35114355/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35114355", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "model organism", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin improved survival/motor outcomes in an ALS worm model with pathway dependencies.", "what_it_does_not_show": "A syndromic worm model does not establish general aging or human healthspan.", "confounders_present": [ "A syndromic worm model does not establish general aging or human healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 2, "pmid": "37551712", "title": "A combination of metformin and galantamine exhibits synergistic benefits in the treatment of sarcopenia.", "citation": "Tezze C, Amendolagine FI, Nogara L et al. A combination of metformin and galantamine exhibits synergistic benefits in the treatment of sarcopenia. JCI insight. 2023.", "doi": "10.1172/jci.insight.168787", "pmcid": "PMC10445681", "url": "https://pubmed.ncbi.nlm.nih.gov/37551712/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/37551712/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID37551712", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin/galantamine combinations improved selected muscle and survival phenotypes.", "what_it_does_not_show": "Combination effects cannot be assigned to metformin alone or generalized to humans.", "confounders_present": [ "Combination effects cannot be assigned to metformin alone or generalized to humans." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 3, "pmid": "33578051", "title": "Protection of nuclear DNA by lifespan-extending compounds in the yeast Saccharomyces cerevisiae.", "citation": "Su WH, Chan CET, Lian T et al. Protection of nuclear DNA by lifespan-extending compounds in the yeast Saccharomyces cerevisiae. Mutation research. 2021.", "doi": "10.1016/j.mrfmmm.2021.111738", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/33578051/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33578051/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33578051", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "model organism", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin affected yeast protection during DNA stress.", "what_it_does_not_show": "Stress survival is not organismal aging-rate or human functional benefit.", "confounders_present": [ "Stress survival is not organismal aging-rate or human functional benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 4, "pmid": "42503569", "title": "p38 MAPK and MDT-15 mediate SKN-1-dependent metformin-induced protection against mitis group streptococci in Caenorhabditis elegans.", "citation": "Al Hatem A, Balasubramaniam B, Villhauer A et al. p38 MAPK and MDT-15 mediate SKN-1-dependent metformin-induced protection against mitis group streptococci in Caenorhabditis elegans. GeroScience. 2026.", "doi": "10.1007/s11357-026-02405-6", "pmcid": "PMC13638828", "url": "https://pubmed.ncbi.nlm.nih.gov/42503569/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/42503569/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID42503569", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "model organism", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin affected worm bacterial-stress resistance through tested pathways.", "what_it_does_not_show": "Infection resistance is distinct from aging and organism-wide healthspan.", "confounders_present": [ "Infection resistance is distinct from aging and organism-wide healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 5, "pmid": "38871078", "title": "Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.", "citation": "Rosell-Díaz M, Petit-Gay A, Molas-Prat C et al. Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men. Metabolism: clinical and experimental. 2024.", "doi": "10.1016/j.metabol.2024.155941", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/38871078/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/38871078/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID38871078", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "Diabetic cohorts showed sex-related microbiome/cognition associations with metformin.", "what_it_does_not_show": "Nonrandomized diabetic exposure cannot establish non-diabetic aging effects.", "confounders_present": [ "Nonrandomized diabetic exposure cannot establish non-diabetic aging effects." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 6, "pmid": "25921843", "title": "Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial.", "citation": "de Kreutzenberg SV, Ceolotto G, Cattelan A et al. Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2015.", "doi": "10.1016/j.numecd.2015.03.007", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/25921843/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/25921843/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "NCT01765946", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "A prediabetes trial altered PBMC/metabolic molecular measures.", "what_it_does_not_show": "Biomarkers do not establish slower aging or generalized healthspan.", "confounders_present": [ "Biomarkers do not establish slower aging or generalized healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 7, "pmid": "30548390", "title": "Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults.", "citation": "Konopka AR, Laurin JL, Schoenberg HM et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging cell. 2019.", "doi": "10.1111/acel.12880", "pmcid": "PMC6351883", "url": "https://pubmed.ncbi.nlm.nih.gov/30548390/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30548390/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID30548390", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "null", "what_it_shows": "Metformin attenuated selected aerobic-training and mitochondrial adaptations in older adults.", "what_it_does_not_show": "This does not prove universal harm or absence of benefits outside the exercise context.", "confounders_present": [ "This does not prove universal harm or absence of benefits outside the exercise context." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 8, "pmid": "33428709", "title": "Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study.", "citation": "Hazuda HP, Pan Q, Florez H et al. Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study. The journals of gerontology. Series A, Biological sciences and medical sciences. 2021.", "doi": "10.1093/gerona/glaa295", "pmcid": "PMC8087265", "url": "https://pubmed.ncbi.nlm.nih.gov/33428709/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33428709/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "DPP_DPPOS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "null", "what_it_shows": "DPPOS frailty analyses favored lifestyle but not metformin.", "what_it_does_not_show": "Prediabetic enrollment and endpoint context do not resolve every aging outcome.", "confounders_present": [ "Prediabetic enrollment and endpoint context do not resolve every aging outcome." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Shared parent randomization/recruitment and outcome ascertainment: DPP_DPPOS" ] }, { "n": 9, "pmid": "40311647", "title": "Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial.", "citation": "Knowler WC, Doherty L, Edelstein SL et al. Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. The lancet. Diabetes & endocrinology. 2025.", "doi": "10.1016/S2213-8587(25)00022-1", "pmcid": "PMC12414453", "url": "https://pubmed.ncbi.nlm.nih.gov/40311647/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/40311647/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "ErratumIn: PMID40319894" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "DPP_DPPOS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "Long DPP follow-up retained an attenuated diabetes-prevention effect, differing by age.", "what_it_does_not_show": "Same study family; prevention in prediabetes does not establish a slower generalized aging trajectory. An erratum is attached.", "confounders_present": [ "Same study family; prevention in prediabetes does not establish a slower generalized aging trajectory. An erratum is attached." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Shared parent randomization/recruitment and outcome ascertainment: DPP_DPPOS" ] }, { "n": 10, "pmid": "11832527", "title": "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.", "citation": "Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England journal of medicine. 2002.", "doi": "10.1056/NEJMoa012512", "pmcid": "PMC1370926", "url": "https://pubmed.ncbi.nlm.nih.gov/11832527/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/11832527/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "DPP_DPPOS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "supports", "what_it_shows": "DPP randomized metformin and lifestyle both prevented diabetes in high-risk nondiabetic participants.", "what_it_does_not_show": "A real disease-specific preventive effect is not proof that metformin slows general aging.", "confounders_present": [ "A real disease-specific preventive effect is not proof that metformin slows general aging." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Shared parent randomization/recruitment and outcome ascertainment: DPP_DPPOS" ] }, { "n": 11, "pmid": "41160096", "title": "Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome.", "citation": "Malin SK, Heiston EM, Battillo DJ et al. Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome. The Journal of clinical endocrinology and metabolism. 2026.", "doi": "10.1210/clinem/dgaf551", "pmcid": "PMC13017335", "url": "https://pubmed.ncbi.nlm.nih.gov/41160096/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/41160096/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID41160096", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "null", "what_it_shows": "Metformin blunted selected exercise-related vascular adaptations.", "what_it_does_not_show": "Treatment-by-exercise context is not universal longevity harm.", "confounders_present": [ "Treatment-by-exercise context is not universal longevity harm." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 12, "pmid": "19878986", "title": "10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.", "citation": "Diabetes Prevention Program Research Group, Knowler WC, Fowler SE et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (London, England). 2009.", "doi": "10.1016/S0140-6736(09)61457-4", "pmcid": "PMC3135022", "url": "https://pubmed.ncbi.nlm.nih.gov/19878986/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/19878986/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "ErratumIn: PMID not supplied" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "DPP_DPPOS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "DPP follow-up found persistent but attenuated diabetes prevention.", "what_it_does_not_show": "Same parent randomization and subsequent treatment changes limit independent-line counting.", "confounders_present": [ "Same parent randomization and subsequent treatment changes limit independent-line counting." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Shared parent randomization/recruitment and outcome ascertainment: DPP_DPPOS" ] }, { "n": 13, "pmid": "18784090", "title": "10-year follow-up of intensive glucose control in type 2 diabetes.", "citation": "Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. The New England journal of medicine. 2008.", "doi": "10.1056/NEJMoa0806470", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/18784090/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/18784090/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "UKPDS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "UKPDS follow-up supported selected long-term benefits after diabetes treatment.", "what_it_does_not_show": "Established diabetes and legacy treatment effects do not establish non-diabetic geroprotection.", "confounders_present": [ "Established diabetes and legacy treatment effects do not establish non-diabetic geroprotection." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Shared parent randomization/recruitment and outcome ascertainment: UKPDS" ] }, { "n": 14, "pmid": "9742977", "title": "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.", "citation": "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England). 1998.", "doi": "", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/9742977/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/9742977/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "ErratumIn: PMID not supplied" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "UKPDS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "UKPDS metformin improved selected diabetic outcomes with differing results in combination arms.", "what_it_does_not_show": "Diabetic disease management and combination context cannot be substituted for general aging.", "confounders_present": [ "Diabetic disease management and combination context cannot be substituted for general aging." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Shared parent randomization/recruitment and outcome ascertainment: UKPDS" ] }, { "n": 15, "pmid": "24119365", "title": "Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study.", "citation": "Cheng YY, Leu HB, Chen TJ et al. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2014.", "doi": "10.1016/j.jstrokecerebrovasdis.2013.09.001", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/24119365/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/24119365/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID24119365", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human observational", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "A diabetic observational cohort associated metformin with fewer strokes.", "what_it_does_not_show": "Confounding by indication and eligibility remain; no nondiabetic randomized aging test.", "confounders_present": [ "Confounding by indication and eligibility remain; no nondiabetic randomized aging test." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 16, "pmid": "25017246", "title": "The use of metformin in patients with prostate cancer and the risk of death.", "citation": "Bensimon L, Yin H, Suissa S et al. The use of metformin in patients with prostate cancer and the risk of death. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014.", "doi": "10.1158/1055-9965.EPI-14-0056", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/25017246/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/25017246/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID25017246", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human observational", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "A diabetic prostate-cancer cohort did not show a clear mortality association benefit.", "what_it_does_not_show": "Disease-specific observational null is not a decisive aging falsifier.", "confounders_present": [ "Disease-specific observational null is not a decisive aging falsifier." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 17, "pmid": "21098347", "title": "Metformin use and mortality among patients with diabetes and atherothrombosis.", "citation": "Roussel R, Travert F, Pasquet B et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Archives of internal medicine. 2010.", "doi": "10.1001/archinternmed.2010.409", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/21098347/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/21098347/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID21098347", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human observational", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin associated with lower mortality in a diabetic atherothrombotic cohort.", "what_it_does_not_show": "Treatment selection and diabetes context remain.", "confounders_present": [ "Treatment selection and diabetes context remain." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 18, "pmid": "39270656", "title": "Metformin decelerates aging clock in male monkeys.", "citation": "Yang Y, Lu X, Liu N et al. Metformin decelerates aging clock in male monkeys. Cell. 2024.", "doi": "10.1016/j.cell.2024.08.021", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/39270656/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/39270656/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID39270656", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin-treated older male monkeys showed selected functional, structural and aging-indicator changes.", "what_it_does_not_show": "Sex-specific nonhuman context and aging-clock shifts are not demonstrated human lifespan extension or literal years rejuvenated.", "confounders_present": [ "Sex-specific nonhuman context and aging-clock shifts are not demonstrated human lifespan extension or literal years rejuvenated." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 19, "pmid": "35197629", "title": "Low-dose metformin targets the lysosomal AMPK pathway through PEN2.", "citation": "Ma T, Tian X, Zhang B et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022.", "doi": "10.1038/s41586-022-04431-8", "pmcid": "PMC8891018", "url": "https://pubmed.ncbi.nlm.nih.gov/35197629/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/35197629/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35197629", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "PEN2/ATP6AP1 experiments identified a lysosomal metformin/AMPK mechanism with model genetic dependencies.", "what_it_does_not_show": "Target/pathway causality is not organism-wide human aging causality.", "confounders_present": [ "Target/pathway causality is not organism-wide human aging causality." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 20, "pmid": "35722742", "title": "Metformin inactivates the cGAS-STING pathway through autophagy and suppresses senescence in nucleus pulposus cells.", "citation": "Ren C, Jin J, Li C et al. Metformin inactivates the cGAS-STING pathway through autophagy and suppresses senescence in nucleus pulposus cells. Journal of cell science. 2022.", "doi": "10.1242/jcs.259738", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/35722742/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/35722742/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35722742", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin altered autophagy/STING and disc-senescence phenotypes in models.", "what_it_does_not_show": "Disease/model endpoints cannot establish general healthspan.", "confounders_present": [ "Disease/model endpoints cannot establish general healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 21, "pmid": "32402267", "title": "Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation.", "citation": "Bharath LP, Agrawal M, McCambridge G et al. Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation. Cell metabolism. 2020.", "doi": "10.1016/j.cmet.2020.04.015", "pmcid": "PMC7217133", "url": "https://pubmed.ncbi.nlm.nih.gov/32402267/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/32402267/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID32402267", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "ex vivo", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin changed aged-human T-cell function ex vivo.", "what_it_does_not_show": "Ex vivo immune rescue is not a treated-human aging trajectory.", "confounders_present": [ "Ex vivo immune rescue is not a treated-human aging trajectory." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 22, "pmid": "23540700", "title": "Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism.", "citation": "Cabreiro F, Au C, Leung KY et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell. 2013.", "doi": "10.1016/j.cell.2013.02.035", "pmcid": "PMC3898468", "url": "https://pubmed.ncbi.nlm.nih.gov/23540700/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/23540700/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID23540700", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "model organism", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin changed worm lifespan through bacterial metabolism and methionine-related context.", "what_it_does_not_show": "Diet and bacterial-strain dependence challenge a uniform direct host-aging mechanism.", "confounders_present": [ "Diet and bacterial-strain dependence challenge a uniform direct host-aging mechanism." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 23, "pmid": "31585093", "title": "Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells.", "citation": "Neumann B, Baror R, Zhao C et al. Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells. Cell stem cell. 2019.", "doi": "10.1016/j.stem.2019.08.015", "pmcid": "PMC6863391", "url": "https://pubmed.ncbi.nlm.nih.gov/31585093/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/31585093/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID31585093", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin restored aged rodent oligodendrocyte precursor/remyelination responses.", "what_it_does_not_show": "Lesion repair is functional but does not establish global aging or human healthspan.", "confounders_present": [ "Lesion repair is functional but does not establish global aging or human healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 24, "pmid": "31944526", "title": "Metformin mediates cardioprotection against aging-induced ischemic necroptosis.", "citation": "Li C, Mu N, Gu C et al. Metformin mediates cardioprotection against aging-induced ischemic necroptosis. Aging cell. 2020.", "doi": "10.1111/acel.13096", "pmcid": "PMC6996959", "url": "https://pubmed.ncbi.nlm.nih.gov/31944526/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/31944526/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID31944526", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin altered aged-mouse ischemic injury and necroptosis-related outcomes.", "what_it_does_not_show": "Acute injury survival is not general longevity.", "confounders_present": [ "Acute injury survival is not general longevity." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 25, "pmid": "36054356", "title": "Metformin prevents age-associated ovarian fibrosis by modulating the immune landscape in female mice.", "citation": "Landry DA, Yakubovich E, Cook DP et al. Metformin prevents age-associated ovarian fibrosis by modulating the immune landscape in female mice. Science advances. 2022.", "doi": "10.1126/sciadv.abq1475", "pmcid": "PMC10848964", "url": "https://pubmed.ncbi.nlm.nih.gov/36054356/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/36054356/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID36054356", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin affected aged mouse ovarian fibrosis/immune measures.", "what_it_does_not_show": "Tissue markers alone cannot establish whole-organism healthspan.", "confounders_present": [ "Tissue markers alone cannot establish whole-organism healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 26, "pmid": "28373282", "title": "Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity.", "citation": "Horiuchi T, Sakata N, Narumi Y et al. Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity. The Journal of biological chemistry. 2017.", "doi": "10.1074/jbc.M116.769380", "pmcid": "PMC5437248", "url": "https://pubmed.ncbi.nlm.nih.gov/28373282/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/28373282/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID28373282", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human observational", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin interacted with HMGB1 and affected inflammatory model outcomes.", "what_it_does_not_show": "Binding and acute inflammation do not identify the primary aging mechanism.", "confounders_present": [ "Binding and acute inflammation do not identify the primary aging mechanism." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 27, "pmid": "33524231", "title": "Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells.", "citation": "Kim H, Yu MR, Lee H et al. Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells. Aging cell. 2021.", "doi": "10.1111/acel.13317", "pmcid": "PMC7884040", "url": "https://pubmed.ncbi.nlm.nih.gov/33524231/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33524231/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33524231", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin preconditioning altered CKD-related mesenchymal-cell senescence/repair measures.", "what_it_does_not_show": "Cell preparation and repair context differ from systemic human treatment.", "confounders_present": [ "Cell preparation and repair context differ from systemic human treatment." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 28, "pmid": "41545663", "title": "Metformin inhibits nuclear egress of chromatin fragments in senescence and aging.", "citation": "Kumazawa T, Xu Y, Wang Y et al. Metformin inhibits nuclear egress of chromatin fragments in senescence and aging. Nature aging. 2026.", "doi": "10.1038/s43587-025-01048-0", "pmcid": "PMC13148253", "url": "https://pubmed.ncbi.nlm.nih.gov/41545663/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/41545663/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID41545663", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "CCF/ALIX pathway work linked metformin/AMPK to aged-mouse intestinal inflammation.", "what_it_does_not_show": "Local inflammation and senescence markers are not generalized human functional benefit.", "confounders_present": [ "Local inflammation and senescence markers are not generalized human functional benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 29, "pmid": "28579457", "title": "Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock.", "citation": "Matsiukevich D, Piraino G, Lahni P et al. Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock. Biochimica et biophysica acta. Molecular basis of disease. 2017.", "doi": "10.1016/j.bbadis.2017.05.027", "pmcid": "PMC5653443", "url": "https://pubmed.ncbi.nlm.nih.gov/28579457/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/28579457/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID28579457", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin affected shock outcomes differently by age and sex in mice.", "what_it_does_not_show": "Acute injury and context-dependent survival do not prove generalized geroprotection.", "confounders_present": [ "Acute injury and context-dependent survival do not prove generalized geroprotection." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 30, "pmid": "29027899", "title": "Metformin extends C. elegans lifespan through lysosomal pathway.", "citation": "Chen J, Ou Y, Li Y et al. Metformin extends C. elegans lifespan through lysosomal pathway. eLife. 2017.", "doi": "10.7554/eLife.31268", "pmcid": "PMC5685485", "url": "https://pubmed.ncbi.nlm.nih.gov/29027899/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/29027899/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID29027899", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "model organism", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Worm genetic work linked metformin longevity effects to lysosomal AMPK/TOR signaling.", "what_it_does_not_show": "Pathway dependence in a model does not establish human mechanism necessity.", "confounders_present": [ "Pathway dependence in a model does not establish human mechanism necessity." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 31, "pmid": "33045408", "title": "Biphasic effect of metformin on human cardiac energetics.", "citation": "Emelyanova L, Bai X, Yan Y et al. Biphasic effect of metformin on human cardiac energetics. Translational research : the journal of laboratory and clinical medicine. 2021.", "doi": "10.1016/j.trsl.2020.10.002", "pmcid": "PMC10655614", "url": "https://pubmed.ncbi.nlm.nih.gov/33045408/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33045408/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33045408", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "in vitro", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Human cardiomyocyte experiments found concentration-dependent metabolic responses to metformin.", "what_it_does_not_show": "In vitro exposure levels and metabolic endpoints cannot establish clinical aging benefit.", "confounders_present": [ "In vitro exposure levels and metabolic endpoints cannot establish clinical aging benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 32, "pmid": "36394755", "title": "Metformin suppresses progression of muscle aging via activation of the AMP kinase-mediated pathways in Drosophila adults.", "citation": "Suzuta S, Nishida H, Ozaki M et al. Metformin suppresses progression of muscle aging via activation of the AMP kinase-mediated pathways in Drosophila adults. European review for medical and pharmacological sciences. 2022.", "doi": "10.26355/eurrev_202211_30158", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/36394755/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/36394755/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID36394755", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "model organism", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Fly experiments linked metformin to muscle function/lifespan and AMPK/TOR pathways.", "what_it_does_not_show": "Species and model context limit inference to humans.", "confounders_present": [ "Species and model context limit inference to humans." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 33, "pmid": "23982736", "title": "Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.", "citation": "Yi G, He Z, Zhou X et al. Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway. International journal of oncology. 2013.", "doi": "10.3892/ijo.2013.2077", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/23982736/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/23982736/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID23982736", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "in vitro", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin induced senescence-related effects in hepatoma cells.", "what_it_does_not_show": "Anticancer cell effects oppose a simplistic universal senescence-erasing description, not all geroprotection.", "confounders_present": [ "Anticancer cell effects oppose a simplistic universal senescence-erasing description, not all geroprotection." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 34, "pmid": "35863470", "title": "Metformin mitigates stress-induced premature senescence by upregulating AMPKα at Ser485 phosphorylation induced SIRT3 expression and inactivating mitochondrial oxidants.", "citation": "Sung JY, Kim SG, Kang YJ et al. Metformin mitigates stress-induced premature senescence by upregulating AMPKα at Ser485 phosphorylation induced SIRT3 expression and inactivating mitochondrial oxidants. Mechanisms of ageing and development. 2022.", "doi": "10.1016/j.mad.2022.111708", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/35863470/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/35863470/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35863470", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "in vitro", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin altered stressed vascular-cell senescence via AMPK/SIRT3-related signaling.", "what_it_does_not_show": "Cellular rescue is not organismal functional benefit.", "confounders_present": [ "Cellular rescue is not organismal functional benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 35, "pmid": "28677234", "title": "Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application.", "citation": "Zhao P, Sui BD, Liu N et al. Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application. Aging cell. 2017.", "doi": "10.1111/acel.12635", "pmcid": "PMC5595695", "url": "https://pubmed.ncbi.nlm.nih.gov/28677234/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/28677234/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "ErratumIn: PMID35112450" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID28677234", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Topical metformin improved selected aged-rodent wound-healing outcomes.", "what_it_does_not_show": "Local route and injury context differ from generalized aging treatment; an erratum is attached.", "confounders_present": [ "Local route and injury context differ from generalized aging treatment; an erratum is attached." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 36, "pmid": "30864661", "title": "Brain Protein Synthesis Rates in the UM-HET3 Mouse Following Treatment With Rapamycin or Rapamycin With Metformin.", "citation": "Reid JJ, Linden MA, Peelor FF et al. Brain Protein Synthesis Rates in the UM-HET3 Mouse Following Treatment With Rapamycin or Rapamycin With Metformin. The journals of gerontology. Series A, Biological sciences and medical sciences. 2020.", "doi": "10.1093/gerona/glz069", "pmcid": "PMC7175973", "url": "https://pubmed.ncbi.nlm.nih.gov/30864661/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30864661/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID30864661", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Rapamycin/metformin combinations altered brain proteins with age/sex dependence.", "what_it_does_not_show": "Combination biomarker effects do not isolate metformin longevity or independent ITP replication.", "confounders_present": [ "Combination biomarker effects do not isolate metformin longevity or independent ITP replication." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 37, "pmid": "37675817", "title": "Cell-type specific impact of metformin on monocyte epigenetic age reversal in virally suppressed older people living with HIV.", "citation": "Corley MJ, Pang APS, Shikuma CM et al. Cell-type specific impact of metformin on monocyte epigenetic age reversal in virally suppressed older people living with HIV. Aging cell. 2024.", "doi": "10.1111/acel.13926", "pmcid": "PMC10776116", "url": "https://pubmed.ncbi.nlm.nih.gov/37675817/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/37675817/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID37675817", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "Metformin in normoglycemic people with HIV altered selected monocyte aging-clock measures.", "what_it_does_not_show": "Cell-type-specific clock shifts and disease context do not establish human healthspan.", "confounders_present": [ "Cell-type-specific clock shifts and disease context do not establish human healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 38, "pmid": "23900241", "title": "Metformin improves healthspan and lifespan in mice.", "citation": "Martin-Montalvo A, Mercken EM, Mitchell SJ et al. Metformin improves healthspan and lifespan in mice. Nature communications. 2013.", "doi": "10.1038/ncomms3192", "pmcid": "PMC3736576", "url": "https://pubmed.ncbi.nlm.nih.gov/23900241/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/23900241/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID23900241", "access_depth": "full_text_partial", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 0:Results:paragraph0, 0:Results:paragraph3. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin extended lifespan and improved fitness in a defined male-mouse experiment while a higher exposure shortened survival.", "what_it_does_not_show": "The second strain's survival result was nonsignificant; concentration, sex and context boundaries prevent generalizing to human aging.", "confounders_present": [ "The second strain's survival result was nonsignificant; concentration, sex and context boundaries prevent generalizing to human aging." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 39, "pmid": "36328749", "title": "Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux.", "citation": "Tai S, Sun J, Zhou Y et al. Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux. Journal of advanced research. 2022.", "doi": "10.1016/j.jare.2021.12.009", "pmcid": "PMC9637479", "url": "https://pubmed.ncbi.nlm.nih.gov/36328749/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/36328749/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "ErratumIn: PMID42379936" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID36328749", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin affected vascular stiffness and senescence-related model measures.", "what_it_does_not_show": "Context-specific vascular outcomes do not establish human geroprotection; an erratum is attached.", "confounders_present": [ "Context-specific vascular outcomes do not establish human geroprotection; an erratum is attached." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 40, "pmid": "35805987", "title": "Metformin Attenuates UVA-Induced Skin Photoaging by Suppressing Mitophagy and the PI3K/AKT/mTOR Pathway.", "citation": "Chen Q, Zhang H, Yang Y et al. Metformin Attenuates UVA-Induced Skin Photoaging by Suppressing Mitophagy and the PI3K/AKT/mTOR Pathway. International journal of molecular sciences. 2022.", "doi": "10.3390/ijms23136960", "pmcid": "PMC9266365", "url": "https://pubmed.ncbi.nlm.nih.gov/35805987/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/35805987/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35805987", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin protected selected UVA-related cell/mouse photoaging measures.", "what_it_does_not_show": "Photodamage is not whole-organism aging trajectory.", "confounders_present": [ "Photodamage is not whole-organism aging trajectory." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 41, "pmid": "33406027", "title": "Short-term metformin ingestion by healthy older adults improves myoblast function.", "citation": "Mahmassani ZS, McKenzie AI, Petrocelli JJ et al. Short-term metformin ingestion by healthy older adults improves myoblast function. American journal of physiology. Cell physiology. 2021.", "doi": "10.1152/ajpcell.00469.2020", "pmcid": "PMC8424538", "url": "https://pubmed.ncbi.nlm.nih.gov/33406027/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33406027/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33406027", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "ex vivo", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "A short older-human exposure study changed myoblast function and inflammatory signatures.", "what_it_does_not_show": "Small short-term tissue assays do not demonstrate slower aging or durable clinical benefit.", "confounders_present": [ "Small short-term tissue assays do not demonstrate slower aging or durable clinical benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 42, "pmid": "33953705", "title": "Metformin Attenuates ROS via FOXO3 Activation in Immune Cells.", "citation": "Hartwig J, Loebel M, Steiner S et al. Metformin Attenuates ROS via FOXO3 Activation in Immune Cells. Frontiers in immunology. 2021.", "doi": "10.3389/fimmu.2021.581799", "pmcid": "PMC8089390", "url": "https://pubmed.ncbi.nlm.nih.gov/33953705/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33953705/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33953705", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "in vitro", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "FOXO3/immune-cell perturbations implicated a pathway in metformin-related ROS responses.", "what_it_does_not_show": "Cell dependency and oxidative measures are not lifespan/healthspan proof.", "confounders_present": [ "Cell dependency and oxidative measures are not lifespan/healthspan proof." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 43, "pmid": "29740925", "title": "Metformin directly targets the H3K27me3 demethylase KDM6A/UTX.", "citation": "Cuyàs E, Verdura S, Llorach-Pares L et al. Metformin directly targets the H3K27me3 demethylase KDM6A/UTX. Aging cell. 2018.", "doi": "10.1111/acel.12772", "pmcid": "PMC6052472", "url": "https://pubmed.ncbi.nlm.nih.gov/29740925/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/29740925/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID29740925", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "in vitro", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin affected KDM6A/chromatin measures in biochemical and model experiments.", "what_it_does_not_show": "Exposure levels and epigenetic endpoints do not establish clinical aging-rate change.", "confounders_present": [ "Exposure levels and epigenetic endpoints do not establish clinical aging-rate change." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 44, "pmid": "31851866", "title": "Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway.", "citation": "Xiao Y, Liu F, Li S et al. Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway. Virulence. 2020.", "doi": "10.1080/21505594.2019.1706305", "pmcid": "PMC6961722", "url": "https://pubmed.ncbi.nlm.nih.gov/31851866/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/31851866/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID31851866", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin affected innate-immune infection resistance through p38-related pathways.", "what_it_does_not_show": "Infection stress resistance is not demonstrated generalized longevity.", "confounders_present": [ "Infection stress resistance is not demonstrated generalized longevity." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 45, "pmid": "27185159", "title": "Metformin Alleviates Altered Erythrocyte Redox Status During Aging in Rats.", "citation": "Garg G, Singh S, Singh AK et al. Metformin Alleviates Altered Erythrocyte Redox Status During Aging in Rats. Rejuvenation research. 2017.", "doi": "10.1089/rej.2016.1826", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/27185159/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/27185159/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID27185159", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Rat metformin experiments altered redox markers.", "what_it_does_not_show": "Redox biomarkers alone cannot cross the aging causal threshold.", "confounders_present": [ "Redox biomarkers alone cannot cross the aging causal threshold." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 46, "pmid": "20304770", "title": "Metformin supplementation and life span in Fischer-344 rats.", "citation": "Smith DL, Elam CF, Mattison JA et al. Metformin supplementation and life span in Fischer-344 rats. The journals of gerontology. Series A, Biological sciences and medical sciences. 2010.", "doi": "10.1093/gerona/glq033", "pmcid": "PMC2854888", "url": "https://pubmed.ncbi.nlm.nih.gov/20304770/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/20304770/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID20304770", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": true, "endogenous": false, "direction": "null", "what_it_shows": "Fischer-344 rat survival did not show a metformin longevity benefit under tested conditions.", "what_it_does_not_show": "A regimen-specific null constrains robustness rather than proving all metformin aging effects absent.", "confounders_present": [ "A regimen-specific null constrains robustness rather than proving all metformin aging effects absent." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 47, "pmid": "31945013", "title": "Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR.", "citation": "Feng X, Pan J, Li J et al. Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR. Aging. 2020.", "doi": "10.18632/aging.102635", "pmcid": "PMC7053618", "url": "https://pubmed.ncbi.nlm.nih.gov/31945013/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/31945013/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID31945013", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin reduced cartilage damage in an injury-induced mouse osteoarthritis model.", "what_it_does_not_show": "Postinjury tissue benefit does not demonstrate broad aging prevention.", "confounders_present": [ "Postinjury tissue benefit does not demonstrate broad aging prevention." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 48, "pmid": "27312235", "title": "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.", "citation": "Strong R, Miller RA, Antebi A et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. Aging cell. 2016.", "doi": "10.1111/acel.12496", "pmcid": "PMC5013015", "url": "https://pubmed.ncbi.nlm.nih.gov/27312235/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/27312235/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "ITP_C2011", "access_depth": "full_text_partial", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:Results:paragraph6, 1:Results:paragraph9. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": true, "endogenous": false, "direction": "null", "what_it_shows": "ITP's original analysis found no statistically significant metformin-alone lifespan benefit; combination survival improved.", "what_it_does_not_show": "Later reanalysis detected a male early-survival signal; historical rapamycin controls do not isolate combination synergy.", "confounders_present": [ "Later reanalysis detected a male early-survival signal; historical rapamycin controls do not isolate combination synergy." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Shared parent randomization/recruitment and outcome ascertainment: ITP_C2011" ] }, { "n": 49, "pmid": "33139960", "title": "Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans.", "citation": "Espada L, Dakhovnik A, Chaudhari P et al. Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans. Nature metabolism. 2020.", "doi": "10.1038/s42255-020-00307-1", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/33139960/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33139960/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33139960", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "model organism", "decisive_perturbation": true, "endogenous": false, "direction": "null", "what_it_shows": "Late-life metformin shortened worm survival in a metabolic-plasticity context.", "what_it_does_not_show": "Age-dependent model toxicity is not direct evidence of human lifespan harm.", "confounders_present": [ "Age-dependent model toxicity is not direct evidence of human lifespan harm." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 50, "pmid": "29579736", "title": "Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice.", "citation": "Weiss R, Fernandez E, Liu Y et al. Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging. 2018.", "doi": "10.18632/aging.101401", "pmcid": "PMC5892694", "url": "https://pubmed.ncbi.nlm.nih.gov/29579736/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/29579736/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID29579736", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Metformin/rapamycin affected female-mouse glucose tolerance.", "what_it_does_not_show": "Combination and metabolic endpoint do not establish metformin-alone longevity.", "confounders_present": [ "Combination and metabolic endpoint do not establish metformin-alone longevity." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 51, "pmid": "38630424", "title": "The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride.", "citation": "Jiang N, Gelfond J, Liu Q et al. The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride. GeroScience. 2024.", "doi": "10.1007/s11357-024-01161-9", "pmcid": "PMC11335987", "url": "https://pubmed.ncbi.nlm.nih.gov/38630424/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/38630424/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "ITP_C2011", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "A Gehan-test reanalysis detected early male survival effects in previously reported ITP data.", "what_it_does_not_show": "Same cohort, altered statistical weighting and retrospective analysis are not independent prospective replication.", "confounders_present": [ "Same cohort, altered statistical weighting and retrospective analysis are not independent prospective replication." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Shared parent randomization/recruitment and outcome ascertainment: ITP_C2011" ] }, { "n": 52, "pmid": "33965434", "title": "Long-term administration of metformin ameliorates age-dependent oxidative stress and cognitive function in rats.", "citation": "Gorgich EAC, Parsaie H, Yarmand S et al. Long-term administration of metformin ameliorates age-dependent oxidative stress and cognitive function in rats. Behavioural brain research. 2021.", "doi": "10.1016/j.bbr.2021.113343", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/33965434/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33965434/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33965434", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Rat experiments supported selected memory/function and redox effects.", "what_it_does_not_show": "Species and endpoint context do not establish human aging slowing.", "confounders_present": [ "Species and endpoint context do not establish human aging slowing." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 53, "pmid": "27418629", "title": "Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.", "citation": "Cameron AR, Morrison VL, Levin D et al. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status. Circulation research. 2016.", "doi": "10.1161/CIRCRESAHA.116.308445", "pmcid": "PMC4990459", "url": "https://pubmed.ncbi.nlm.nih.gov/27418629/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/27418629/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "NCT00473876", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "Model and nondiabetic heart-failure analyses supported selected anti-inflammatory effects.", "what_it_does_not_show": "Inflammatory measures and disease context do not establish generalized healthspan.", "confounders_present": [ "Inflammatory measures and disease context do not establish generalized healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 54, "pmid": "22564993", "title": "Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.", "citation": "Bonanni B, Puntoni M, Cazzaniga M et al. Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012.", "doi": "10.1200/JCO.2011.39.3769", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/22564993/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/22564993/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID22564993", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "null", "what_it_shows": "Presurgical breast-cancer metformin did not improve overall Ki67, with exploratory insulin-resistance heterogeneity.", "what_it_does_not_show": "Subgroup interaction and a proliferation surrogate do not establish cancer prevention or aging benefit.", "confounders_present": [ "Subgroup interaction and a proliferation surrogate do not establish cancer prevention or aging benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 55, "pmid": "20810669", "title": "Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.", "citation": "Hosono K, Endo H, Takahashi H et al. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer prevention research (Philadelphia, Pa.). 2010.", "doi": "10.1158/1940-6207.CAPR-10-0186", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/20810669/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/20810669/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID20810669", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "supports", "what_it_shows": "A small nondiabetic trial reduced a colorectal aberrant-crypt-foci surrogate.", "what_it_does_not_show": "A short surrogate trial is not cancer-incidence or lifespan proof.", "confounders_present": [ "A short surrogate trial is not cancer-incidence or lifespan proof." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 56, "pmid": "9693934", "title": "Effect of metformin on food intake in obese subjects.", "citation": "Paolisso G, Amato L, Eccellente R et al. Effect of metformin on food intake in obese subjects. European journal of clinical investigation. 1998.", "doi": "10.1046/j.1365-2362.1998.00304.x", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/9693934/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/9693934/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID9693934", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "Metformin reduced food intake and weight in nondiabetic obesity.", "what_it_does_not_show": "Caloric intake is a competing mediator and cannot be assumed aging-specific benefit.", "confounders_present": [ "Caloric intake is a competing mediator and cannot be assumed aging-specific benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 57, "pmid": "30536182", "title": "Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial.", "citation": "Nanni O, Amadori D, De Censi A et al. Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial. Breast cancer research and treatment. 2019.", "doi": "10.1007/s10549-018-05070-2", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/30536182/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30536182/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID30536182", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "null", "what_it_shows": "MYME did not improve breast-cancer progression-free survival with metformin addition.", "what_it_does_not_show": "Chemotherapy combination in cancer is not a generalized aging intervention.", "confounders_present": [ "Chemotherapy combination in cancer is not a generalized aging intervention." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 58, "pmid": "33830437", "title": "Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial.", "citation": "Ladeiras-Lopes R, Sampaio F, Leite S et al. Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial. Endocrine. 2021.", "doi": "10.1007/s12020-021-02687-0", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/33830437/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33830437/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33830437", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "supports", "what_it_shows": "MET-DIME improved selected diastolic Doppler measures without a clear peak-VO2 or SF36 difference.", "what_it_does_not_show": "Imaging/physiology changes are not demonstrated broad functional healthspan.", "confounders_present": [ "Imaging/physiology changes are not demonstrated broad functional healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 59, "pmid": "25041462", "title": "Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.", "citation": "Bannister CA, Holden SE, Jenkins-Jones S et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes, obesity & metabolism. 2014.", "doi": "10.1111/dom.12354", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/25041462/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/25041462/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID25041462", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human observational", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "An observational comparison reported survival advantages for metformin-treated diabetics over matched nondiabetic controls.", "what_it_does_not_show": "Treatment eligibility, diabetes differences and censoring can create selection bias; controls did not receive randomized metformin.", "confounders_present": [ "Treatment eligibility, diabetes differences and censoring can create selection bias; controls did not receive randomized metformin." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 60, "pmid": "31557380", "title": "Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial.", "citation": "Walton RG, Dungan CM, Long DE et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial. Aging cell. 2019.", "doi": "10.1111/acel.13039", "pmcid": "PMC6826125", "url": "https://pubmed.ncbi.nlm.nih.gov/31557380/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/31557380/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "ErratumIn: PMID32141718" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "NCT02308228", "access_depth": "full_text_partial", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:RESULTS:paragraph8, 1:RESULTS:paragraph10. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "null", "what_it_shows": "MASTERS found less exercise-induced muscle-mass gain with metformin in older adults.", "what_it_does_not_show": "Strength differences were trends without statistical significance; muscle adaptation is not all aging outcomes. An erratum is attached.", "confounders_present": [ "Strength differences were trends without statistical significance; muscle adaptation is not all aging outcomes. An erratum is attached." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 61, "pmid": "37131166", "title": "Comparison of long-term effects of metformin on longevity between people with type 2 diabetes and matched non-diabetic controls.", "citation": "Stevenson-Hoare J, Leonenko G, Escott-Price V. Comparison of long-term effects of metformin on longevity between people with type 2 diabetes and matched non-diabetic controls. BMC public health. 2023.", "doi": "10.1186/s12889-023-15764-y", "pmcid": "PMC10155360", "url": "https://pubmed.ncbi.nlm.nih.gov/37131166/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/37131166/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID37131166", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human observational", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Longer UK cohort comparison did not sustain diabetic-metformin users' apparent survival advantage over nondiabetic controls.", "what_it_does_not_show": "Diabetes burden and nonrandomized treatment prevent attributing shorter survival to drug toxicity.", "confounders_present": [ "Diabetes burden and nonrandomized treatment prevent attributing shorter survival to drug toxicity." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] } ], "verification_summary": { "load_bearing_claims_checked": 65, "verified": 65, "unverified": 0, "contradicted": 0, "note": "Verified attribution is distinct from mechanism truth or complete body access." }, "factual_issues_found": [], "cap_rules_applied": [], "cap_precedence_resolutions": [ { "collision": "Perturbation in a defined setting versus broader inference", "subclaim_scope_cap_binds_on": "Metformin slows biological aging in non-diabetic humans and extends healthspan.", "subclaim_scope_threshold_binds_on": "The precise experimentally tested subclaim scope", "resolution": "Animal functional/survival interventions cross within defined model scopes, including constrained Ε. Human biomarkers do not cross the aging threshold. Animal positive results cannot supply the human claim, and one weak animal or observational leg does not negate the stronger constrained model case.", "note": "Convergent lines are assessed as a set; one weak leg is not re-capped over the assembled case." } ], "boundary_check_BGD": [ { "subclaim_id": "SC1", "field_valid_perturbation_quote": "\n- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension\n- Must separate developmental effects from true aging effects\n- Biomarker change alone does NOT satisfy this threshold", "qualifying_evidence_present": "no", "qualifying_evidence_citation": "", "gamma_hard_rules_triggered": [ "Human associations and biomarker-only changes do not establish the broad causal claim.", "Model perturbations bind their tested species and phenotype, not an untested human scope.", "Positive treatment effects are checked for specific mechanism attribution; negative trials require target engagement before mechanistic falsification." ], "disease_phenotype_relevance": "yes", "perturbation_result_positive": "no", "perturbation_result_note": "Metformin has specific experimentally demonstrated molecular/pathway effects, but aging attribution cannot be established by AMPK, redox, senescence or clock markers alone.", "ceiling_from_boundary_check": "Γ" }, { "subclaim_id": "SC2", "field_valid_perturbation_quote": "\n- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension\n- Must separate developmental effects from true aging effects\n- Biomarker change alone does NOT satisfy this threshold", "qualifying_evidence_present": "yes", "qualifying_evidence_citation": "PMID39270656, PMID23540700, PMID36394755, PMID23900241", "gamma_hard_rules_triggered": [ "Human associations and biomarker-only changes do not establish the broad causal claim.", "Model perturbations bind their tested species and phenotype, not an untested human scope.", "Positive treatment effects are checked for specific mechanism attribution; negative trials require target engagement before mechanistic falsification." ], "disease_phenotype_relevance": "yes", "perturbation_result_positive": "yes", "perturbation_result_note": "Defined model interventions change survival/function in worms, flies and selected mammals. Ε is restricted to demonstrated species, genotype, timing and exposure; negative and toxic contexts prevent a universal model claim.", "ceiling_from_boundary_check": "Δ or higher" }, { "subclaim_id": "SC3", "field_valid_perturbation_quote": "\n- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension\n- Must separate developmental effects from true aging effects\n- Biomarker change alone does NOT satisfy this threshold", "qualifying_evidence_present": "no", "qualifying_evidence_citation": "", "gamma_hard_rules_triggered": [ "Human associations and biomarker-only changes do not establish the broad causal claim.", "Model perturbations bind their tested species and phenotype, not an untested human scope.", "Positive treatment effects are checked for specific mechanism attribution; negative trials require target engagement before mechanistic falsification." ], "disease_phenotype_relevance": "yes", "perturbation_result_positive": "no", "perturbation_result_note": "Non-diabetic high-risk people obtain genuine diabetes prevention, but this does not establish slower general aging or broad functional healthspan. Short biomarkers and diabetic observational survival cannot supply that missing clinical claim.", "ceiling_from_boundary_check": "Γ" } ], "thresholds_tested": [ { "subclaim_id": "SC1", "threshold": "Δ", "requirement_quoted": "Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.", "satisfied": "no", "supporting_evidence": [], "what_would_cross_it": "Establish the proposed aging pathway through functional/lifespan outcomes with specific mediator intervention, not only biomarkers." }, { "subclaim_id": "SC2", "threshold": "Δ", "requirement_quoted": "Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.", "satisfied": "yes", "supporting_evidence": [ "[18] Metformin-treated older male monkeys showed selected functional, structural and aging-indicator changes.", "[22] Metformin changed worm lifespan through bacterial metabolism and methionine-related context.", "[32] Fly experiments linked metformin to muscle function/lifespan and AMPK/TOR pathways.", "[38] Metformin extended lifespan and improved fitness in a defined male-mouse experiment while a higher exposure shortened survival." ], "what_would_cross_it": "" }, { "subclaim_id": "SC2", "threshold": "Ε", "requirement_quoted": "Requires causal effect in constrained contexts, backgrounds, or species.", "satisfied": "yes", "supporting_evidence": [ "[18] Metformin-treated older male monkeys showed selected functional, structural and aging-indicator changes.", "[22] Metformin changed worm lifespan through bacterial metabolism and methionine-related context.", "[32] Fly experiments linked metformin to muscle function/lifespan and AMPK/TOR pathways.", "[38] Metformin extended lifespan and improved fitness in a defined male-mouse experiment while a higher exposure shortened survival." ], "what_would_cross_it": "" }, { "subclaim_id": "SC2", "threshold": "Ζ", "requirement_quoted": "Requires:\n- Reproducible intervention effects\n- Mechanistic narrowing\n- Evidence not reducible to general sickness, caloric reduction, or developmental artifacts", "satisfied": "no", "supporting_evidence": [ "[18] Metformin-treated older male monkeys showed selected functional, structural and aging-indicator changes.", "[22] Metformin changed worm lifespan through bacterial metabolism and methionine-related context.", "[32] Fly experiments linked metformin to muscle function/lifespan and AMPK/TOR pathways.", "[38] Metformin extended lifespan and improved fitness in a defined male-mouse experiment while a higher exposure shortened survival." ], "what_would_cross_it": "Cross Ζ by reproducible mechanistic narrowing across contexts, ruling out diet, sickness and developmental explanations without ignoring internal negative controls." }, { "subclaim_id": "SC3", "threshold": "Δ", "requirement_quoted": "Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.", "satisfied": "no", "supporting_evidence": [], "what_would_cross_it": "A randomized non-diabetic human study must demonstrate durable prespecified aging-related functional/healthspan trajectory changes, separating single-disease prevention and caloric/weight effects." } ], "generalization_check": { "generalization_tested": "no", "context_boundary_mapped": "yes", "internal_negative_controls": [ "Rat and original ITP tests lack a clear broad lifespan benefit under their analyses.", "Late-worm exposure and higher mouse exposure can shorten survival.", "MASTERS muscle-mass adaptation was blunted, with strength differences not statistically significant.", "DPP benefits concern high-risk prediabetes rather than a general aging trajectory." ], "note": "Model outcomes vary by exposure, sex, age, strain, diet and bacterial context. Human exercise trials supply internal functional boundaries. A constrained model success is not a general human survival result." }, "falsification_patterns_met": [], "pitfalls_flagged": [ { "pitfall": "Biological clock equals healthspan", "where": "Cell-type clocks and monkey clock estimates are not literal years of human rejuvenation." }, { "pitfall": "Same-data reanalysis", "where": "The Gehan reanalysis changes interpretation of original ITP data, not independent replication." }, { "pitfall": "Historical combination control", "where": "Metformin/rapamycin was compared with earlier rapamycin cohorts rather than a contemporaneous factorial arm." }, { "pitfall": "Indication and eligibility bias", "where": "Diabetic treated people versus nondiabetic controls are not randomized metformin-treated nondiabetic people." } ], "causal_tally_audit": { "tally_claimed_by_document": 21, "tally_after_audit": 21, "items_rejected": [ "Null and negative contrasts are discriminators, not positive threshold crossings. Reports and replications are not independent causal lines.", "The tally counts reports with discriminating intervention contrasts, including negative results; it is not a count of positive causal crossings.", "Shared parent trials and multiple manipulations within a study remain grouped." ] }, "steelman": { "case_one_rung_higher": "Case for Δ: DPP prevents diabetes in nondiabetic people, monkey function and aging indicators improve, and selected model lifespan outcomes are positive. This crosses a disease-specific prevention threshold, but not the preregistered conjunctive claim that human general aging slows and broad healthspan improves.", "case_one_rung_lower": "Case for Β: human aging evidence is dominated by biomarkers and observational diabetic survival. Multiple controlled model outcomes and defined pathway dependencies supply partial mechanistic support, making Γ more faithful than an association-only score.", "which_rejected": "Retain Γ for human geroprotection and Ε for constrained model outcomes. A diabetes-prevention benefit is acknowledged rather than relabeled as no human benefit.", "blocking_cap_threshold_or_missing_experiment": "Missing experiment: Conduct a prespecified randomized non-diabetic older-human trial measuring durable clinical/function trajectories, with baseline metabolic strata, nutrition/weight monitoring and mechanistic engagement; keep disease-specific prevention and aging outcomes separate." }, "final_score": { "hsef_level": "Γ", "hsef_descriptor": "Mechanistically plausible, partial system support", "confidence": "Moderate", "confidence_rationale": "61 primary reports with 3 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.", "rests_on_non_peer_reviewed_work": false, "rationale": "Overall Γ applies to SC3. Context-specific animal function/survival and genuine prevention of diabetes do not establish generalized human aging slowing. The strongest model results are retained at Ε within their tested settings, with dose, timing, sex, diet and statistical boundaries explicit." }, "role_of_mechanism": { "classification": "epiphenomenon", "derivation_step_matched": 2, "derivation": "For the exact generalized human-aging claim, a causal dependency on metformin-responsive pathways has not been demonstrated. Step 2 is an operational unresolved-role classification, not denial of causal diabetes prevention or model mechanisms; no general-aging primary-driver role is assigned.", "tournament_used_as_tiebreaker": false, "note": "Derived from causal direction, not tournament rank." }, "extended_scoring_MSD": { "momentum": { "value": "Mechanistic only", "artifact": "Older-monkey work (PMID39270656), short human mechanistic work (PMID37675817) and model studies pursue mechanisms. DPP is a completed diabetes-prevention programme, not a completed general-aging trial; no pending human geroprotection result with verified timing was identified.", "justification": "Older-monkey work (PMID39270656), short human mechanistic work (PMID37675817) and model studies pursue mechanisms. DPP is a completed diabetes-prevention programme, not a completed general-aging trial; no pending human geroprotection result with verified timing was identified." }, "stability": { "value": "Stable", "trigger": "No specific pending result with a verified completion trigger was identified in this bounded search; Stable follows the framework definition, not a forecast of permanent truth.", "justification": "No specific pending result with a verified completion trigger was identified in this bounded search; Stable follows the framework definition, not a forecast of permanent truth." }, "divergence": { "implied_level": null, "implied_level_basis": "No single field-implied level is defensible from conflicting framings.", "assessed_level": "Γ", "gap_in_rungs": null, "value": "Contested", "justification": "No manufactured field consensus or arithmetic gap." }, "calibration_note": "M/S/D never modify HSEF level or confidence." }, "change_record": { "applies": false, "prior_level": "none assigned", "prior_confidence": null, "prior_source": null, "derived_before_consulting_prior": true, "new_level": "Γ", "direction": "newly assigned", "what_moved_it": "Fresh primary evidence appraisal; not blinded.", "divergence_from_other_reviewers": null }, "proposed_decisive_experiments": [ { "name": "Registered boundary experiment", "experiment": "Conduct a prespecified randomized non-diabetic older-human trial measuring durable clinical/function trajectories, with baseline metabolic strata, nutrition/weight monitoring and mechanistic engagement; keep disease-specific prevention and aging outcomes separate.", "readout": "Registered multimorbidity/functional endpoints over adequate follow-up, with pathway engagement", "critical_control": "Matched treatment, allocation/blinding assessment, diet/exercise exposure and weight-related mediation", "supporting_result": "Clinically meaningful durable broad function/healthspan benefit aligned with specific mechanism beyond single-disease prevention", "falsifying_result": "Verified engagement without the registered function/healthspan benefit at adequate power, or prespecified functional deterioration" } ], "knowledge_gaps": [ { "name": "Gap 1", "statement": "No selected completed randomized demonstration of slower general human aging.", "relevance": "Limits mechanism identification or scope." }, { "name": "Gap 2", "statement": "Model dose, late-life timing and sex boundaries remain unresolved.", "relevance": "Limits mechanism identification or scope." }, { "name": "Gap 3", "statement": "Biological-clock shifts need clinical outcome validation.", "relevance": "Limits mechanism identification or scope." }, { "name": "Gap 4", "statement": "Food intake, microbiome and disease-specific effects must be separated.", "relevance": "Limits mechanism identification or scope." } ], "review_metadata": { "review_date": "2026-10-09", "reviewer": "Codex", "evidence_base_note": "61 primary reports; literature cutoff 2026-10-09; source examination UTC date 2026-10-10; bounded critical review, not exhaustive systematic review.", "literature_tools_available": true, "literature_tools_note": "Life Sciences Literature PubMed/Entrez; separately logged public original-body retrieval; No Consensus or Scite calls used; PubMed primary records and separately logged public original-body retrieval only.", "skill_version": "5.3", "validator_run": "Exact package-bundled v5.3 validator: PASS, zero FAIL findings; rerun after sealing.", "validator_warnings_addressed": "No warnings.", "limits": "Bounded critical review; not systematic review, complete-abstract audit, complete-paper audit, blind calibration or independent peer review.", "consensus_consistency_audit": "2026-10-09; supplementary provenance/source reconciliation; original grading retained; prior grades visible." }, "is_calibration_entry": { "value": false, "entry_role": "not_calibration", "blind_graded": null, "completed_blinded_calibration": false, "expected_band_sealed_at": "", "target_sha256": "", "target_authorship": "not applicable", "target_author_saw_review": null, "future_run_status": "not prepared", "unblinded_reason": "Ranking categorical verdict and index guidance were visible. No completed blinded calibration claimed." }, "upper_ladder_check": { "final_level_below_zeta": true, "equivalents_considered": [ { "kind": "mendelian_randomization", "available": false, "why_not_sufficient": "No convergence establishes the full registered claim. Positive narrower results are retained without re-capping an assembled causal set; their scopes and distinct failure modes are stated separately." }, { "kind": "natural_experiment", "available": false, "why_not_sufficient": "No convergence establishes the full registered claim. Positive narrower results are retained without re-capping an assembled causal set; their scopes and distinct failure modes are stated separately." }, { "kind": "dose_response_across_populations", "available": false, "why_not_sufficient": "No convergence establishes the full registered claim. Positive narrower results are retained without re-capping an assembled causal set; their scopes and distinct failure modes are stated separately." }, { "kind": "withdrawal_rechallenge", "available": false, "why_not_sufficient": "No convergence establishes the full registered claim. Positive narrower results are retained without re-capping an assembled causal set; their scopes and distinct failure modes are stated separately." }, { "kind": "therapeutic_perturbation_hard_endpoint", "available": false, "why_not_sufficient": "No convergence establishes the full registered claim. Positive narrower results are retained without re-capping an assembled causal set; their scopes and distinct failure modes are stated separately." } ], "convergence_present": false, "cap_reapplied_to_convergent_set": false }, "provenance_header": { "sources_total": 61, "claims_total": 65, "claims_verified": 65, "claims_unverified": 0, "claims_contradicted": 0, "tier_a_sources": 61, "generated_by": "Codex; HSEF v5.3", "gate_passed": true }, "claims": [ { "id": "C1", "text": "Metformin improved survival/motor outcomes in an ALS worm model with pathway dependencies. A syndromic worm model does not establish general aging or human healthspan.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 1 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C2", "text": "Metformin/galantamine combinations improved selected muscle and survival phenotypes. Combination effects cannot be assigned to metformin alone or generalized to humans.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 2 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C3", "text": "Metformin affected yeast protection during DNA stress. Stress survival is not organismal aging-rate or human functional benefit.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 3 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C4", "text": "Metformin affected worm bacterial-stress resistance through tested pathways. Infection resistance is distinct from aging and organism-wide healthspan.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 4 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C5", "text": "Diabetic cohorts showed sex-related microbiome/cognition associations with metformin. Nonrandomized diabetic exposure cannot establish non-diabetic aging effects.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 5 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C6", "text": "A prediabetes trial altered PBMC/metabolic molecular measures. Biomarkers do not establish slower aging or generalized healthspan.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 6 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C7", "text": "Metformin attenuated selected aerobic-training and mitochondrial adaptations in older adults. This does not prove universal harm or absence of benefits outside the exercise context.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 7 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C8", "text": "DPPOS frailty analyses favored lifestyle but not metformin. Prediabetic enrollment and endpoint context do not resolve every aging outcome.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 8 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C9", "text": "Long DPP follow-up retained an attenuated diabetes-prevention effect, differing by age. Same study family; prevention in prediabetes does not establish a slower generalized aging trajectory. An erratum is attached.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 9 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C10", "text": "DPP randomized metformin and lifestyle both prevented diabetes in high-risk nondiabetic participants. A real disease-specific preventive effect is not proof that metformin slows general aging.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 10 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C11", "text": "Metformin blunted selected exercise-related vascular adaptations. Treatment-by-exercise context is not universal longevity harm.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 11 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C12", "text": "DPP follow-up found persistent but attenuated diabetes prevention. Same parent randomization and subsequent treatment changes limit independent-line counting.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 12 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C13", "text": "UKPDS follow-up supported selected long-term benefits after diabetes treatment. Established diabetes and legacy treatment effects do not establish non-diabetic geroprotection.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 13 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C14", "text": "UKPDS metformin improved selected diabetic outcomes with differing results in combination arms. Diabetic disease management and combination context cannot be substituted for general aging.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 14 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C15", "text": "A diabetic observational cohort associated metformin with fewer strokes. Confounding by indication and eligibility remain; no nondiabetic randomized aging test.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 15 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C16", "text": "A diabetic prostate-cancer cohort did not show a clear mortality association benefit. Disease-specific observational null is not a decisive aging falsifier.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 16 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C17", "text": "Metformin associated with lower mortality in a diabetic atherothrombotic cohort. Treatment selection and diabetes context remain.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 17 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C18", "text": "Metformin-treated older male monkeys showed selected functional, structural and aging-indicator changes. Sex-specific nonhuman context and aging-clock shifts are not demonstrated human lifespan extension or literal years rejuvenated.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 18 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C19", "text": "PEN2/ATP6AP1 experiments identified a lysosomal metformin/AMPK mechanism with model genetic dependencies. Target/pathway causality is not organism-wide human aging causality.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 19 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C20", "text": "Metformin altered autophagy/STING and disc-senescence phenotypes in models. Disease/model endpoints cannot establish general healthspan.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 20 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C21", "text": "Metformin changed aged-human T-cell function ex vivo. Ex vivo immune rescue is not a treated-human aging trajectory.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 21 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C22", "text": "Metformin changed worm lifespan through bacterial metabolism and methionine-related context. Diet and bacterial-strain dependence challenge a uniform direct host-aging mechanism.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 22 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C23", "text": "Metformin restored aged rodent oligodendrocyte precursor/remyelination responses. Lesion repair is functional but does not establish global aging or human healthspan.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 23 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C24", "text": "Metformin altered aged-mouse ischemic injury and necroptosis-related outcomes. Acute injury survival is not general longevity.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 24 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C25", "text": "Metformin affected aged mouse ovarian fibrosis/immune measures. Tissue markers alone cannot establish whole-organism healthspan.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 25 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C26", "text": "Metformin interacted with HMGB1 and affected inflammatory model outcomes. Binding and acute inflammation do not identify the primary aging mechanism.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 26 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C27", "text": "Metformin preconditioning altered CKD-related mesenchymal-cell senescence/repair measures. Cell preparation and repair context differ from systemic human treatment.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 27 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C28", "text": "CCF/ALIX pathway work linked metformin/AMPK to aged-mouse intestinal inflammation. Local inflammation and senescence markers are not generalized human functional benefit.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 28 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C29", "text": "Metformin affected shock outcomes differently by age and sex in mice. Acute injury and context-dependent survival do not prove generalized geroprotection.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 29 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C30", "text": "Worm genetic work linked metformin longevity effects to lysosomal AMPK/TOR signaling. Pathway dependence in a model does not establish human mechanism necessity.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 30 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C31", "text": "Human cardiomyocyte experiments found concentration-dependent metabolic responses to metformin. In vitro exposure levels and metabolic endpoints cannot establish clinical aging benefit.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 31 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C32", "text": "Fly experiments linked metformin to muscle function/lifespan and AMPK/TOR pathways. Species and model context limit inference to humans.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 32 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C33", "text": "Metformin induced senescence-related effects in hepatoma cells. Anticancer cell effects oppose a simplistic universal senescence-erasing description, not all geroprotection.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 33 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C34", "text": "Metformin altered stressed vascular-cell senescence via AMPK/SIRT3-related signaling. Cellular rescue is not organismal functional benefit.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 34 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C35", "text": "Topical metformin improved selected aged-rodent wound-healing outcomes. Local route and injury context differ from generalized aging treatment; an erratum is attached.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 35 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C36", "text": "Rapamycin/metformin combinations altered brain proteins with age/sex dependence. Combination biomarker effects do not isolate metformin longevity or independent ITP replication.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 36 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C37", "text": "Metformin in normoglycemic people with HIV altered selected monocyte aging-clock measures. Cell-type-specific clock shifts and disease context do not establish human healthspan.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 37 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C38", "text": "Metformin extended lifespan and improved fitness in a defined male-mouse experiment while a higher exposure shortened survival. The second strain's survival result was nonsignificant; concentration, sex and context boundaries prevent generalizing to human aging.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 38 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 0:Results:paragraph0, 0:Results:paragraph3. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C39", "text": "Metformin affected vascular stiffness and senescence-related model measures. Context-specific vascular outcomes do not establish human geroprotection; an erratum is attached.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 39 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C40", "text": "Metformin protected selected UVA-related cell/mouse photoaging measures. Photodamage is not whole-organism aging trajectory.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 40 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C41", "text": "A short older-human exposure study changed myoblast function and inflammatory signatures. Small short-term tissue assays do not demonstrate slower aging or durable clinical benefit.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 41 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C42", "text": "FOXO3/immune-cell perturbations implicated a pathway in metformin-related ROS responses. Cell dependency and oxidative measures are not lifespan/healthspan proof.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 42 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C43", "text": "Metformin affected KDM6A/chromatin measures in biochemical and model experiments. Exposure levels and epigenetic endpoints do not establish clinical aging-rate change.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 43 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C44", "text": "Metformin affected innate-immune infection resistance through p38-related pathways. Infection stress resistance is not demonstrated generalized longevity.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 44 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C45", "text": "Rat metformin experiments altered redox markers. Redox biomarkers alone cannot cross the aging causal threshold.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 45 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C46", "text": "Fischer-344 rat survival did not show a metformin longevity benefit under tested conditions. A regimen-specific null constrains robustness rather than proving all metformin aging effects absent.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 46 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C47", "text": "Metformin reduced cartilage damage in an injury-induced mouse osteoarthritis model. Postinjury tissue benefit does not demonstrate broad aging prevention.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 47 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C48", "text": "ITP's original analysis found no statistically significant metformin-alone lifespan benefit; combination survival improved. Later reanalysis detected a male early-survival signal; historical rapamycin controls do not isolate combination synergy.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 48 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:Results:paragraph6, 1:Results:paragraph9. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C49", "text": "Late-life metformin shortened worm survival in a metabolic-plasticity context. Age-dependent model toxicity is not direct evidence of human lifespan harm.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 49 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C50", "text": "Metformin/rapamycin affected female-mouse glucose tolerance. Combination and metabolic endpoint do not establish metformin-alone longevity.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 50 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C51", "text": "A Gehan-test reanalysis detected early male survival effects in previously reported ITP data. Same cohort, altered statistical weighting and retrospective analysis are not independent prospective replication.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 51 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C52", "text": "Rat experiments supported selected memory/function and redox effects. Species and endpoint context do not establish human aging slowing.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 52 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C53", "text": "Model and nondiabetic heart-failure analyses supported selected anti-inflammatory effects. Inflammatory measures and disease context do not establish generalized healthspan.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 53 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C54", "text": "Presurgical breast-cancer metformin did not improve overall Ki67, with exploratory insulin-resistance heterogeneity. Subgroup interaction and a proliferation surrogate do not establish cancer prevention or aging benefit.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 54 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C55", "text": "A small nondiabetic trial reduced a colorectal aberrant-crypt-foci surrogate. A short surrogate trial is not cancer-incidence or lifespan proof.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 55 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C56", "text": "Metformin reduced food intake and weight in nondiabetic obesity. Caloric intake is a competing mediator and cannot be assumed aging-specific benefit.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 56 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C57", "text": "MYME did not improve breast-cancer progression-free survival with metformin addition. Chemotherapy combination in cancer is not a generalized aging intervention.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 57 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C58", "text": "MET-DIME improved selected diastolic Doppler measures without a clear peak-VO2 or SF36 difference. Imaging/physiology changes are not demonstrated broad functional healthspan.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 58 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C59", "text": "An observational comparison reported survival advantages for metformin-treated diabetics over matched nondiabetic controls. Treatment eligibility, diabetes differences and censoring can create selection bias; controls did not receive randomized metformin.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 59 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C60", "text": "MASTERS found less exercise-induced muscle-mass gain with metformin in older adults. Strength differences were trends without statistical significance; muscle adaptation is not all aging outcomes. An erratum is attached.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 60 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:RESULTS:paragraph8, 1:RESULTS:paragraph10. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "C61", "text": "Longer UK cohort comparison did not sustain diabetic-metformin users' apparent survival advantage over nondiabetic controls. Diabetes burden and nonrandomized treatment prevent attributing shorter survival to drug toxicity.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 61 ], "verification": "verified", "verified_against": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-10", "note": "" }, { "id": "CSC1", "text": "Metformin has specific experimentally demonstrated molecular/pathway effects, but aging attribution cannot be established by AMPK, redox, senescence or clock markers alone.", "carries_number": false, "load_bearing_for": [ "SC1" ], "source_ns": [ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61 ], "verification": "verified", "verified_against": "Synthesis of examined primary result/limit cards; framework level is adjudication.", "verified_on": "2026-10-10", "note": "" }, { "id": "CSC2", "text": "Defined model interventions change survival/function in worms, flies and selected mammals. Ε is restricted to demonstrated species, genotype, timing and exposure; negative and toxic contexts prevent a universal model claim.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61 ], "verification": "verified", "verified_against": "Synthesis of examined primary result/limit cards; framework level is adjudication.", "verified_on": "2026-10-10", "note": "" }, { "id": "CSC3", "text": "Non-diabetic high-risk people obtain genuine diabetes prevention, but this does not establish slower general aging or broad functional healthspan. Short biomarkers and diabetic observational survival cannot supply that missing clinical claim.", "carries_number": false, "load_bearing_for": [ "SC3" ], "source_ns": [ 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 21, 26, 31, 33, 34, 37, 41, 42, 43, 53, 54, 55, 56, 57, 58, 59, 60, 61 ], "verification": "verified", "verified_against": "Synthesis of examined primary result/limit cards; framework level is adjudication.", "verified_on": "2026-10-10", "note": "" }, { "id": "CH", "text": "Metformin has model geroprotection and human diabetes-prevention evidence; slowing general aging in people without diabetes remains unproved.", "carries_number": false, "load_bearing_for": [ "SC3" ], "source_ns": [ 38, 18, 10, 60, 48, 51 ], "verification": "verified", "verified_against": "Bounded synthesis of examined sources; score is adjudication.", "verified_on": "2026-10-10", "note": "" } ], "citation_ledger": [ { "n": 1, "citation": "Xu H, Jia C, Cheng C et al. Activation of autophagy attenuates motor deficits and extends lifespan in a C. elegans model of ALS. Free radical biology & medicine. 2022.", "tier": "A", "kind": "primary", "pmid": "35114355", "doi": "10.1016/j.freeradbiomed.2022.01.030", "url": "https://pubmed.ncbi.nlm.nih.gov/35114355/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35114355", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C1", "CSC1", "CSC2" ] }, { "n": 2, "citation": "Tezze C, Amendolagine FI, Nogara L et al. A combination of metformin and galantamine exhibits synergistic benefits in the treatment of sarcopenia. JCI insight. 2023.", "tier": "A", "kind": "primary", "pmid": "37551712", "doi": "10.1172/jci.insight.168787", "url": "https://pubmed.ncbi.nlm.nih.gov/37551712/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID37551712", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C2", "CSC1", "CSC2" ] }, { "n": 3, "citation": "Su WH, Chan CET, Lian T et al. Protection of nuclear DNA by lifespan-extending compounds in the yeast Saccharomyces cerevisiae. Mutation research. 2021.", "tier": "A", "kind": "primary", "pmid": "33578051", "doi": "10.1016/j.mrfmmm.2021.111738", "url": "https://pubmed.ncbi.nlm.nih.gov/33578051/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33578051", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C3", "CSC1", "CSC2" ] }, { "n": 4, "citation": "Al Hatem A, Balasubramaniam B, Villhauer A et al. p38 MAPK and MDT-15 mediate SKN-1-dependent metformin-induced protection against mitis group streptococci in Caenorhabditis elegans. GeroScience. 2026.", "tier": "A", "kind": "primary", "pmid": "42503569", "doi": "10.1007/s11357-026-02405-6", "url": "https://pubmed.ncbi.nlm.nih.gov/42503569/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID42503569", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C4", "CSC1", "CSC2" ] }, { "n": 5, "citation": "Rosell-Díaz M, Petit-Gay A, Molas-Prat C et al. Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men. Metabolism: clinical and experimental. 2024.", "tier": "A", "kind": "rct", "pmid": "38871078", "doi": "10.1016/j.metabol.2024.155941", "url": "https://pubmed.ncbi.nlm.nih.gov/38871078/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID38871078", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C5", "CSC1", "CSC2", "CSC3" ] }, { "n": 6, "citation": "de Kreutzenberg SV, Ceolotto G, Cattelan A et al. Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2015.", "tier": "A", "kind": "rct", "pmid": "25921843", "doi": "10.1016/j.numecd.2015.03.007", "url": "https://pubmed.ncbi.nlm.nih.gov/25921843/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "NCT01765946", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C6", "CSC1", "CSC2", "CSC3" ] }, { "n": 7, "citation": "Konopka AR, Laurin JL, Schoenberg HM et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging cell. 2019.", "tier": "A", "kind": "rct", "pmid": "30548390", "doi": "10.1111/acel.12880", "url": "https://pubmed.ncbi.nlm.nih.gov/30548390/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID30548390", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C7", "CSC1", "CSC2", "CSC3" ] }, { "n": 8, "citation": "Hazuda HP, Pan Q, Florez H et al. Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study. The journals of gerontology. Series A, Biological sciences and medical sciences. 2021.", "tier": "A", "kind": "rct", "pmid": "33428709", "doi": "10.1093/gerona/glaa295", "url": "https://pubmed.ncbi.nlm.nih.gov/33428709/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "DPP_DPPOS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C8", "CSC1", "CSC2", "CSC3" ] }, { "n": 9, "citation": "Knowler WC, Doherty L, Edelstein SL et al. Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. The lancet. Diabetes & endocrinology. 2025.", "tier": "A", "kind": "rct", "pmid": "40311647", "doi": "10.1016/S2213-8587(25)00022-1", "url": "https://pubmed.ncbi.nlm.nih.gov/40311647/", "status_flags": [ "ErratumIn: PMID40319894" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "DPP_DPPOS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C9", "CSC1", "CSC2", "CSC3" ] }, { "n": 10, "citation": "Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England journal of medicine. 2002.", "tier": "A", "kind": "rct", "pmid": "11832527", "doi": "10.1056/NEJMoa012512", "url": "https://pubmed.ncbi.nlm.nih.gov/11832527/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "DPP_DPPOS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C10", "CSC1", "CSC2", "CSC3", "CH" ] }, { "n": 11, "citation": "Malin SK, Heiston EM, Battillo DJ et al. Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome. The Journal of clinical endocrinology and metabolism. 2026.", "tier": "A", "kind": "rct", "pmid": "41160096", "doi": "10.1210/clinem/dgaf551", "url": "https://pubmed.ncbi.nlm.nih.gov/41160096/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID41160096", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C11", "CSC1", "CSC2", "CSC3" ] }, { "n": 12, "citation": "Diabetes Prevention Program Research Group, Knowler WC, Fowler SE et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (London, England). 2009.", "tier": "A", "kind": "rct", "pmid": "19878986", "doi": "10.1016/S0140-6736(09)61457-4", "url": "https://pubmed.ncbi.nlm.nih.gov/19878986/", "status_flags": [ "ErratumIn: PMID not supplied" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "DPP_DPPOS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C12", "CSC1", "CSC2", "CSC3" ] }, { "n": 13, "citation": "Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. The New England journal of medicine. 2008.", "tier": "A", "kind": "rct", "pmid": "18784090", "doi": "10.1056/NEJMoa0806470", "url": "https://pubmed.ncbi.nlm.nih.gov/18784090/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "UKPDS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C13", "CSC1", "CSC2", "CSC3" ] }, { "n": 14, "citation": "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England). 1998.", "tier": "A", "kind": "rct", "pmid": "9742977", "doi": "", "url": "https://pubmed.ncbi.nlm.nih.gov/9742977/", "status_flags": [ "ErratumIn: PMID not supplied" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "UKPDS", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C14", "CSC1", "CSC2", "CSC3" ] }, { "n": 15, "citation": "Cheng YY, Leu HB, Chen TJ et al. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2014.", "tier": "A", "kind": "primary", "pmid": "24119365", "doi": "10.1016/j.jstrokecerebrovasdis.2013.09.001", "url": "https://pubmed.ncbi.nlm.nih.gov/24119365/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID24119365", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C15", "CSC1", "CSC2", "CSC3" ] }, { "n": 16, "citation": "Bensimon L, Yin H, Suissa S et al. The use of metformin in patients with prostate cancer and the risk of death. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014.", "tier": "A", "kind": "primary", "pmid": "25017246", "doi": "10.1158/1055-9965.EPI-14-0056", "url": "https://pubmed.ncbi.nlm.nih.gov/25017246/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID25017246", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C16", "CSC1", "CSC2", "CSC3" ] }, { "n": 17, "citation": "Roussel R, Travert F, Pasquet B et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Archives of internal medicine. 2010.", "tier": "A", "kind": "primary", "pmid": "21098347", "doi": "10.1001/archinternmed.2010.409", "url": "https://pubmed.ncbi.nlm.nih.gov/21098347/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID21098347", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C17", "CSC1", "CSC2", "CSC3" ] }, { "n": 18, "citation": "Yang Y, Lu X, Liu N et al. Metformin decelerates aging clock in male monkeys. Cell. 2024.", "tier": "A", "kind": "primary", "pmid": "39270656", "doi": "10.1016/j.cell.2024.08.021", "url": "https://pubmed.ncbi.nlm.nih.gov/39270656/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID39270656", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C18", "CSC1", "CSC2", "CH" ] }, { "n": 19, "citation": "Ma T, Tian X, Zhang B et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022.", "tier": "A", "kind": "primary", "pmid": "35197629", "doi": "10.1038/s41586-022-04431-8", "url": "https://pubmed.ncbi.nlm.nih.gov/35197629/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35197629", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C19", "CSC1", "CSC2" ] }, { "n": 20, "citation": "Ren C, Jin J, Li C et al. Metformin inactivates the cGAS-STING pathway through autophagy and suppresses senescence in nucleus pulposus cells. Journal of cell science. 2022.", "tier": "A", "kind": "primary", "pmid": "35722742", "doi": "10.1242/jcs.259738", "url": "https://pubmed.ncbi.nlm.nih.gov/35722742/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35722742", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C20", "CSC1", "CSC2" ] }, { "n": 21, "citation": "Bharath LP, Agrawal M, McCambridge G et al. Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation. Cell metabolism. 2020.", "tier": "A", "kind": "primary", "pmid": "32402267", "doi": "10.1016/j.cmet.2020.04.015", "url": "https://pubmed.ncbi.nlm.nih.gov/32402267/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID32402267", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C21", "CSC1", "CSC2", "CSC3" ] }, { "n": 22, "citation": "Cabreiro F, Au C, Leung KY et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell. 2013.", "tier": "A", "kind": "primary", "pmid": "23540700", "doi": "10.1016/j.cell.2013.02.035", "url": "https://pubmed.ncbi.nlm.nih.gov/23540700/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID23540700", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C22", "CSC1", "CSC2" ] }, { "n": 23, "citation": "Neumann B, Baror R, Zhao C et al. Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells. Cell stem cell. 2019.", "tier": "A", "kind": "primary", "pmid": "31585093", "doi": "10.1016/j.stem.2019.08.015", "url": "https://pubmed.ncbi.nlm.nih.gov/31585093/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID31585093", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C23", "CSC1", "CSC2" ] }, { "n": 24, "citation": "Li C, Mu N, Gu C et al. Metformin mediates cardioprotection against aging-induced ischemic necroptosis. Aging cell. 2020.", "tier": "A", "kind": "primary", "pmid": "31944526", "doi": "10.1111/acel.13096", "url": "https://pubmed.ncbi.nlm.nih.gov/31944526/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID31944526", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C24", "CSC1", "CSC2" ] }, { "n": 25, "citation": "Landry DA, Yakubovich E, Cook DP et al. Metformin prevents age-associated ovarian fibrosis by modulating the immune landscape in female mice. Science advances. 2022.", "tier": "A", "kind": "primary", "pmid": "36054356", "doi": "10.1126/sciadv.abq1475", "url": "https://pubmed.ncbi.nlm.nih.gov/36054356/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID36054356", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C25", "CSC1", "CSC2" ] }, { "n": 26, "citation": "Horiuchi T, Sakata N, Narumi Y et al. Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity. The Journal of biological chemistry. 2017.", "tier": "A", "kind": "primary", "pmid": "28373282", "doi": "10.1074/jbc.M116.769380", "url": "https://pubmed.ncbi.nlm.nih.gov/28373282/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID28373282", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C26", "CSC1", "CSC2", "CSC3" ] }, { "n": 27, "citation": "Kim H, Yu MR, Lee H et al. Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells. Aging cell. 2021.", "tier": "A", "kind": "primary", "pmid": "33524231", "doi": "10.1111/acel.13317", "url": "https://pubmed.ncbi.nlm.nih.gov/33524231/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33524231", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C27", "CSC1", "CSC2" ] }, { "n": 28, "citation": "Kumazawa T, Xu Y, Wang Y et al. Metformin inhibits nuclear egress of chromatin fragments in senescence and aging. Nature aging. 2026.", "tier": "A", "kind": "primary", "pmid": "41545663", "doi": "10.1038/s43587-025-01048-0", "url": "https://pubmed.ncbi.nlm.nih.gov/41545663/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID41545663", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C28", "CSC1", "CSC2" ] }, { "n": 29, "citation": "Matsiukevich D, Piraino G, Lahni P et al. Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock. Biochimica et biophysica acta. Molecular basis of disease. 2017.", "tier": "A", "kind": "primary", "pmid": "28579457", "doi": "10.1016/j.bbadis.2017.05.027", "url": "https://pubmed.ncbi.nlm.nih.gov/28579457/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID28579457", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C29", "CSC1", "CSC2" ] }, { "n": 30, "citation": "Chen J, Ou Y, Li Y et al. Metformin extends C. elegans lifespan through lysosomal pathway. eLife. 2017.", "tier": "A", "kind": "primary", "pmid": "29027899", "doi": "10.7554/eLife.31268", "url": "https://pubmed.ncbi.nlm.nih.gov/29027899/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID29027899", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C30", "CSC1", "CSC2" ] }, { "n": 31, "citation": "Emelyanova L, Bai X, Yan Y et al. Biphasic effect of metformin on human cardiac energetics. Translational research : the journal of laboratory and clinical medicine. 2021.", "tier": "A", "kind": "primary", "pmid": "33045408", "doi": "10.1016/j.trsl.2020.10.002", "url": "https://pubmed.ncbi.nlm.nih.gov/33045408/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33045408", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C31", "CSC1", "CSC2", "CSC3" ] }, { "n": 32, "citation": "Suzuta S, Nishida H, Ozaki M et al. Metformin suppresses progression of muscle aging via activation of the AMP kinase-mediated pathways in Drosophila adults. European review for medical and pharmacological sciences. 2022.", "tier": "A", "kind": "primary", "pmid": "36394755", "doi": "10.26355/eurrev_202211_30158", "url": "https://pubmed.ncbi.nlm.nih.gov/36394755/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID36394755", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C32", "CSC1", "CSC2" ] }, { "n": 33, "citation": "Yi G, He Z, Zhou X et al. Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway. International journal of oncology. 2013.", "tier": "A", "kind": "primary", "pmid": "23982736", "doi": "10.3892/ijo.2013.2077", "url": "https://pubmed.ncbi.nlm.nih.gov/23982736/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID23982736", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C33", "CSC1", "CSC2", "CSC3" ] }, { "n": 34, "citation": "Sung JY, Kim SG, Kang YJ et al. Metformin mitigates stress-induced premature senescence by upregulating AMPKα at Ser485 phosphorylation induced SIRT3 expression and inactivating mitochondrial oxidants. Mechanisms of ageing and development. 2022.", "tier": "A", "kind": "primary", "pmid": "35863470", "doi": "10.1016/j.mad.2022.111708", "url": "https://pubmed.ncbi.nlm.nih.gov/35863470/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35863470", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C34", "CSC1", "CSC2", "CSC3" ] }, { "n": 35, "citation": "Zhao P, Sui BD, Liu N et al. Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application. Aging cell. 2017.", "tier": "A", "kind": "primary", "pmid": "28677234", "doi": "10.1111/acel.12635", "url": "https://pubmed.ncbi.nlm.nih.gov/28677234/", "status_flags": [ "ErratumIn: PMID35112450" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID28677234", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C35", "CSC1", "CSC2" ] }, { "n": 36, "citation": "Reid JJ, Linden MA, Peelor FF et al. Brain Protein Synthesis Rates in the UM-HET3 Mouse Following Treatment With Rapamycin or Rapamycin With Metformin. The journals of gerontology. Series A, Biological sciences and medical sciences. 2020.", "tier": "A", "kind": "primary", "pmid": "30864661", "doi": "10.1093/gerona/glz069", "url": "https://pubmed.ncbi.nlm.nih.gov/30864661/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID30864661", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C36", "CSC1", "CSC2" ] }, { "n": 37, "citation": "Corley MJ, Pang APS, Shikuma CM et al. Cell-type specific impact of metformin on monocyte epigenetic age reversal in virally suppressed older people living with HIV. Aging cell. 2024.", "tier": "A", "kind": "rct", "pmid": "37675817", "doi": "10.1111/acel.13926", "url": "https://pubmed.ncbi.nlm.nih.gov/37675817/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID37675817", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C37", "CSC1", "CSC2", "CSC3" ] }, { "n": 38, "citation": "Martin-Montalvo A, Mercken EM, Mitchell SJ et al. Metformin improves healthspan and lifespan in mice. Nature communications. 2013.", "tier": "A", "kind": "primary", "pmid": "23900241", "doi": "10.1038/ncomms3192", "url": "https://pubmed.ncbi.nlm.nih.gov/23900241/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID23900241", "access_depth": "full_text_partial", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 0:Results:paragraph0, 0:Results:paragraph3. No complete-paper or supplement audit claimed.", "carries_claims": [ "C38", "CSC1", "CSC2", "CH" ] }, { "n": 39, "citation": "Tai S, Sun J, Zhou Y et al. Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux. Journal of advanced research. 2022.", "tier": "A", "kind": "primary", "pmid": "36328749", "doi": "10.1016/j.jare.2021.12.009", "url": "https://pubmed.ncbi.nlm.nih.gov/36328749/", "status_flags": [ "ErratumIn: PMID42379936" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID36328749", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C39", "CSC1", "CSC2" ] }, { "n": 40, "citation": "Chen Q, Zhang H, Yang Y et al. Metformin Attenuates UVA-Induced Skin Photoaging by Suppressing Mitophagy and the PI3K/AKT/mTOR Pathway. International journal of molecular sciences. 2022.", "tier": "A", "kind": "primary", "pmid": "35805987", "doi": "10.3390/ijms23136960", "url": "https://pubmed.ncbi.nlm.nih.gov/35805987/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID35805987", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C40", "CSC1", "CSC2" ] }, { "n": 41, "citation": "Mahmassani ZS, McKenzie AI, Petrocelli JJ et al. Short-term metformin ingestion by healthy older adults improves myoblast function. American journal of physiology. Cell physiology. 2021.", "tier": "A", "kind": "primary", "pmid": "33406027", "doi": "10.1152/ajpcell.00469.2020", "url": "https://pubmed.ncbi.nlm.nih.gov/33406027/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33406027", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C41", "CSC1", "CSC2", "CSC3" ] }, { "n": 42, "citation": "Hartwig J, Loebel M, Steiner S et al. Metformin Attenuates ROS via FOXO3 Activation in Immune Cells. Frontiers in immunology. 2021.", "tier": "A", "kind": "primary", "pmid": "33953705", "doi": "10.3389/fimmu.2021.581799", "url": "https://pubmed.ncbi.nlm.nih.gov/33953705/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33953705", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C42", "CSC1", "CSC2", "CSC3" ] }, { "n": 43, "citation": "Cuyàs E, Verdura S, Llorach-Pares L et al. Metformin directly targets the H3K27me3 demethylase KDM6A/UTX. Aging cell. 2018.", "tier": "A", "kind": "primary", "pmid": "29740925", "doi": "10.1111/acel.12772", "url": "https://pubmed.ncbi.nlm.nih.gov/29740925/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID29740925", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C43", "CSC1", "CSC2", "CSC3" ] }, { "n": 44, "citation": "Xiao Y, Liu F, Li S et al. Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway. Virulence. 2020.", "tier": "A", "kind": "primary", "pmid": "31851866", "doi": "10.1080/21505594.2019.1706305", "url": "https://pubmed.ncbi.nlm.nih.gov/31851866/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID31851866", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C44", "CSC1", "CSC2" ] }, { "n": 45, "citation": "Garg G, Singh S, Singh AK et al. Metformin Alleviates Altered Erythrocyte Redox Status During Aging in Rats. Rejuvenation research. 2017.", "tier": "A", "kind": "primary", "pmid": "27185159", "doi": "10.1089/rej.2016.1826", "url": "https://pubmed.ncbi.nlm.nih.gov/27185159/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID27185159", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C45", "CSC1", "CSC2" ] }, { "n": 46, "citation": "Smith DL, Elam CF, Mattison JA et al. Metformin supplementation and life span in Fischer-344 rats. The journals of gerontology. Series A, Biological sciences and medical sciences. 2010.", "tier": "A", "kind": "primary", "pmid": "20304770", "doi": "10.1093/gerona/glq033", "url": "https://pubmed.ncbi.nlm.nih.gov/20304770/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID20304770", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C46", "CSC1", "CSC2" ] }, { "n": 47, "citation": "Feng X, Pan J, Li J et al. Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR. Aging. 2020.", "tier": "A", "kind": "primary", "pmid": "31945013", "doi": "10.18632/aging.102635", "url": "https://pubmed.ncbi.nlm.nih.gov/31945013/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID31945013", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C47", "CSC1", "CSC2" ] }, { "n": 48, "citation": "Strong R, Miller RA, Antebi A et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. Aging cell. 2016.", "tier": "A", "kind": "primary", "pmid": "27312235", "doi": "10.1111/acel.12496", "url": "https://pubmed.ncbi.nlm.nih.gov/27312235/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "ITP_C2011", "access_depth": "full_text_partial", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:Results:paragraph6, 1:Results:paragraph9. No complete-paper or supplement audit claimed.", "carries_claims": [ "C48", "CSC1", "CSC2", "CH" ] }, { "n": 49, "citation": "Espada L, Dakhovnik A, Chaudhari P et al. Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans. Nature metabolism. 2020.", "tier": "A", "kind": "primary", "pmid": "33139960", "doi": "10.1038/s42255-020-00307-1", "url": "https://pubmed.ncbi.nlm.nih.gov/33139960/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33139960", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C49", "CSC1", "CSC2" ] }, { "n": 50, "citation": "Weiss R, Fernandez E, Liu Y et al. Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging. 2018.", "tier": "A", "kind": "primary", "pmid": "29579736", "doi": "10.18632/aging.101401", "url": "https://pubmed.ncbi.nlm.nih.gov/29579736/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID29579736", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C50", "CSC1", "CSC2" ] }, { "n": 51, "citation": "Jiang N, Gelfond J, Liu Q et al. The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride. GeroScience. 2024.", "tier": "A", "kind": "primary", "pmid": "38630424", "doi": "10.1007/s11357-024-01161-9", "url": "https://pubmed.ncbi.nlm.nih.gov/38630424/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "ITP_C2011", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C51", "CSC1", "CSC2", "CH" ] }, { "n": 52, "citation": "Gorgich EAC, Parsaie H, Yarmand S et al. Long-term administration of metformin ameliorates age-dependent oxidative stress and cognitive function in rats. Behavioural brain research. 2021.", "tier": "A", "kind": "primary", "pmid": "33965434", "doi": "10.1016/j.bbr.2021.113343", "url": "https://pubmed.ncbi.nlm.nih.gov/33965434/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33965434", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C52", "CSC1", "CSC2" ] }, { "n": 53, "citation": "Cameron AR, Morrison VL, Levin D et al. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status. Circulation research. 2016.", "tier": "A", "kind": "rct", "pmid": "27418629", "doi": "10.1161/CIRCRESAHA.116.308445", "url": "https://pubmed.ncbi.nlm.nih.gov/27418629/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "NCT00473876", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C53", "CSC1", "CSC2", "CSC3" ] }, { "n": 54, "citation": "Bonanni B, Puntoni M, Cazzaniga M et al. Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012.", "tier": "A", "kind": "rct", "pmid": "22564993", "doi": "10.1200/JCO.2011.39.3769", "url": "https://pubmed.ncbi.nlm.nih.gov/22564993/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID22564993", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C54", "CSC1", "CSC2", "CSC3" ] }, { "n": 55, "citation": "Hosono K, Endo H, Takahashi H et al. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer prevention research (Philadelphia, Pa.). 2010.", "tier": "A", "kind": "rct", "pmid": "20810669", "doi": "10.1158/1940-6207.CAPR-10-0186", "url": "https://pubmed.ncbi.nlm.nih.gov/20810669/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID20810669", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C55", "CSC1", "CSC2", "CSC3" ] }, { "n": 56, "citation": "Paolisso G, Amato L, Eccellente R et al. Effect of metformin on food intake in obese subjects. European journal of clinical investigation. 1998.", "tier": "A", "kind": "rct", "pmid": "9693934", "doi": "10.1046/j.1365-2362.1998.00304.x", "url": "https://pubmed.ncbi.nlm.nih.gov/9693934/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID9693934", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C56", "CSC1", "CSC2", "CSC3" ] }, { "n": 57, "citation": "Nanni O, Amadori D, De Censi A et al. Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial. Breast cancer research and treatment. 2019.", "tier": "A", "kind": "rct", "pmid": "30536182", "doi": "10.1007/s10549-018-05070-2", "url": "https://pubmed.ncbi.nlm.nih.gov/30536182/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID30536182", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C57", "CSC1", "CSC2", "CSC3" ] }, { "n": 58, "citation": "Ladeiras-Lopes R, Sampaio F, Leite S et al. Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial. Endocrine. 2021.", "tier": "A", "kind": "rct", "pmid": "33830437", "doi": "10.1007/s12020-021-02687-0", "url": "https://pubmed.ncbi.nlm.nih.gov/33830437/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID33830437", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C58", "CSC1", "CSC2", "CSC3" ] }, { "n": 59, "citation": "Bannister CA, Holden SE, Jenkins-Jones S et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes, obesity & metabolism. 2014.", "tier": "A", "kind": "primary", "pmid": "25041462", "doi": "10.1111/dom.12354", "url": "https://pubmed.ncbi.nlm.nih.gov/25041462/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID25041462", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C59", "CSC1", "CSC2", "CSC3" ] }, { "n": 60, "citation": "Walton RG, Dungan CM, Long DE et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial. Aging cell. 2019.", "tier": "A", "kind": "rct", "pmid": "31557380", "doi": "10.1111/acel.13039", "url": "https://pubmed.ncbi.nlm.nih.gov/31557380/", "status_flags": [ "ErratumIn: PMID32141718" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "NCT02308228", "access_depth": "full_text_partial", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:RESULTS:paragraph8, 1:RESULTS:paragraph10. No complete-paper or supplement audit claimed.", "carries_claims": [ "C60", "CSC1", "CSC2", "CSC3", "CH" ] }, { "n": 61, "citation": "Stevenson-Hoare J, Leonenko G, Escott-Price V. Comparison of long-term effects of metformin on longevity between people with type 2 diabetes and matched non-diabetic controls. BMC public health. 2023.", "tier": "A", "kind": "primary", "pmid": "37131166", "doi": "10.1186/s12889-023-15764-y", "url": "https://pubmed.ncbi.nlm.nih.gov/37131166/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-10", "status_checked_on": "2026-10-10", "study_id": "PMID37131166", "access_depth": "abstract_metadata", "access_note": "Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed.", "carries_claims": [ "C61", "CSC1", "CSC2", "CSC3" ] } ], "independence_basis": { "required": false, "lines": [], "shared_failure_mode_checked": true, "note": "Different publications, laboratories and agents do not automatically form independent causal lines. No nominal Ζ or higher is assigned." }, "consensus_validation": { "score_after": { "hsef_level": "Γ", "hsef_descriptor": "Mechanistically plausible, partial system support", "confidence": "Moderate", "confidence_rationale": "61 primary reports with 3 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.", "rests_on_non_peer_reviewed_work": false, "rationale": "Overall Γ applies to SC3. Context-specific animal function/survival and genuine prevention of diabetes do not establish generalized human aging slowing. The strongest model results are retained at Ε within their tested settings, with dose, timing, sex, diet and statistical boundaries explicit." }, "primary_comparisons": [ { "doi": "10.1016/j.eclinm.2026.103874", "study_group": "METFORAGING", "access_depth": "Original primary abstract and full-text passages; newly published within cutoff, supplemental, outside original ledger", "pmid": "42023167", "result_comparison": "40 older non-diabetic adults with HIV randomized; n=35 completed; primary PhenoAge EAA difference -1.02 years (95% CI -5.30 to 3.26; p=.627); no significant between-group epigenetic biomarker differences; no healthspan endpoint.", "source_type": "primary study report" }, { "doi": "10.1093/gerona/glaa295", "study_group": "DPP_DPPOS", "access_depth": "Original primary published report abstract; frozen source ledger", "pmid": "33428709", "result_comparison": "Published frailty outcome in diabetes prevention follow-up; narrow prediabetes context and no generalized aging proof. Consensus review relied partly on old preliminary framing; published primary source already present.", "source_type": "primary study report" }, { "doi": "10.64898/2026.07.27.26359055", "study_group": "NCT02570672", "access_depth": "medRxiv preprint abstract/full text and registered protocol; explicitly unreviewed; supplemental outside original 61", "pmid": "42620010", "result_comparison": "Older adults with prediabetes/glucose intolerance randomized; primary Fried frailty outcome not clearly positive and year-1 result driven by weight-loss item; secondary FI modestly improved. Narrow Δ signal cannot establish broad non-diabetic geroprotection; would impose Low confidence if final grading rested on it.", "source_type": "primary study report" } ], "grade_changed": false, "raw_paths": [ "consensus-browser-response.md", "browser-thread.json", "consensus-search-raw.json", "consensus-fetch-1a8ceb62113b58db9503e31eab8fe509.json" ], "queries": [ "metformin effects on human aging (browser request in browser-thread.json)", "human:true metformin geroprotection healthy non-diabetic older adults randomized TAME", "supplemental registered older-adult prediabetes frailty trial protocol/result search" ], "cutoff": "2026-10-09", "score_before": { "hsef_level": "Γ", "hsef_descriptor": "Mechanistically plausible, partial system support", "confidence": "Moderate", "confidence_rationale": "61 primary reports with 3 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.", "rests_on_non_peer_reviewed_work": false, "rationale": "Overall Γ applies to SC3. Context-specific animal function/survival and genuine prevention of diabetes do not establish generalized human aging slowing. The strongest model results are retained at Ε within their tested settings, with dose, timing, sex, diet and statistical boundaries explicit." }, "conclusion": "METFORAGING is a small biomarker pilot with an imprecise null. The prediabetes frailty preprint has a null/weight-driven primary functional outcome and a modest secondary FI signal. Neither crosses broad SC3; both supplements remain outside original count.", "addendum_path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\addendum.md", "original_counts_preserved": { "claims_total": 65, "sources_total": 61 }, "completed": true, "independent_blinded_audit": false, "provider_mode": "Consensus Pro browser thread plus Consensus keyword search/fetch; supplemental PubMed/protocol check", "primary_comparison_count": 3, "protocol_sources": [ { "role": "Confirms endpoint hierarchy; not an outcome report and not counted as a primary result or report.", "source_type": "registered protocol", "doi": "10.1093/gerona/glz069" } ], "secondary_comparisons": [ { "pmid": "36281624", "doi": "10.1111/acel.13733", "source_type": "secondary systematic review/meta-analysis; not primary", "access_depth": "Consensus-cited systematic review; abstract/full-text appraisal bounded; absent from frozen selected-records primary report ledger", "study_group": "animal lifespan systematic review", "result_comparison": "Heterogeneous lifespan effects; no significant overall lifespan extension in mice or nematodes, with subgroup-specific worm findings. Secondary synthesis relevant to SC2, not an original primary comparison and not evidence for SC3." } ], "source_id_reconciliation": [ { "study_group": "METFORAGING", "status": "absent", "id": "PMID 42023167 / DOI 10.1016/j.eclinm.2026.103874", "location": "supplemental primary RCT report, within cutoff" }, { "study_group": "DPP_DPPOS", "status": "present", "id": "PMID 33428709 / DOI 10.1093/gerona/glaa295", "location": "selected-records.json/evidence; original report" }, { "study_group": "animal lifespan synthesis", "status": "absent", "id": "PMID 36281624 / DOI 10.1111/acel.13733", "location": "secondary systematic review/meta-analysis; not a primary report" }, { "study_group": "NCT02570672", "status": "absent", "id": "PMID 42620010 / DOI 10.64898/2026.07.27.26359055", "location": "supplemental non-peer-reviewed preprint, within cutoff" }, { "study_group": "NCT02570672", "status": "absent", "id": "DOI 10.1093/gerona/glz069", "location": "registered trial protocol; design/endpoint source only, not an outcome report or primary report count unit" } ], "additional_original_source_receipts": [], "status": "completed_retrospective_original_source_reconciliation", "raw_receipts": [ { "path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\consensus-browser-response.md", "sha256": "6b0fc53b4b80c39b9a4068ba1fa84d4a4385e960278b1c2f3c3f23206dde578f" }, { "path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\browser-thread.json", "sha256": "970e60134102ce74ece153d437ca2d3ef5822b92a5e548946584146a40917e9a" }, { "path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\consensus-search-raw.json", "sha256": "b61712e145bedbae262f41de9b0ed948d447c58419e446cf315b60d7aa92f03f" }, { "path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\consensus-fetch-1a8ceb62113b58db9503e31eab8fe509.json", "sha256": "ae7bc70d3669e327b19d3e3075b090a266cfd058c6a4aede03ae4f5e417b30fe" } ], "manifest_source": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\final-structured-consensus-validation.json", "literature_cutoff_preserved": true } }